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ABSTRACT
THE ROLE OF PROTEOME IN CELLULAR Zn2+ TRAFFICKING AND IN THE ABILITY OF
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The University of Wisconsin-Milwaukee, 2016
Under the Supervision of Professor David H. Petering

Zinc is an essential biological trace metal used in as many as 3000 Zn-proteins, about 10% of the
eukaryotic proteome, as either a structural constituent or a catalytic cofactor. These proteins
include the zinc fingers, the most prevalent transcription factors that bind a wide range of gene
promoters and thus regulate gene expression. A eukaryotic cell contains several hundred
micromolar of Zn2+- almost all of it is bound to specific Zn-proteins. Recently, Zn2+ has been
reported to serve as a regulatory signal and a neurotransmitter, suggesting that there also
exists a dynamic Zn2+ pool in cells. These findings led to the synthesis of a wide range of
fluorescent sensors to image intracellular mobile Zn2+. Despite extensive knowledge about
thousands of Zn-proteins, the Zn2+ trafficking pathway from its entry into the cytosol by
transporters to the formation of Zn-proteins is not well understood. This present work has
studied the role of proteome in cellular Zn2+ trafficking using fluorescent zinc sensors, including
FluoZin-3, Zinquin (ZQ), TSQ, Newport Green (NPG) and Zinpyr-1 (ZP1). The titration of
proteome pre-treated with FluoZin-3, a relatively high affinity Zn2+ sensor with the stability
constant of 15 nM, with Zn2+ has revealed that proteome contains a significant number of high
ii

affinity, non-specific Zn2+ binding sites, with the stability constants on the order of 10-10 M. The
discovery of these high affinity binding sites of proteome suggested that along with Znmetallothionein, proteome too can serve as a possible intermediate along the way to the
formation of native Zn-proteins. Moreover, this finding raises the question how the majority of
the fluorescent zinc sensors with the stability constants ranging from micromolar to nanomolar
image intracellular labile Zn2+ by circumventing the proteome’s high zinc buffering capacity.
Interestingly, the thiol binding reagents, N-ethylmaleimide (NEM) and DTNB abolished these
high affinity sites, revealing the involvement of proteomic sulfhydryl groups in these Zn 2+
binding sites. The loss of proteome’s zinc buffering capacity upon sulfhydryl modification can
explain how the sensors bind the dynamic Zn2+ pool by surpassing the proteome’s high Zn2+
binding affinity. For example, Zinquin, a high affinity sensor with K d of 2 nM, could bind the
mobile Zn2+ only when the proteome was significantly modified by the reaction under
investigation, such as the liberation of proteomic Zn2+ by nitric oxide, which reacts with the
sulfhydryl groups and thus reduces proteome’s buffering capacity. In case of unperturbed
proteome, these sensors either are unable to compete for mobile Zn2+ with proteome’s high
affinity Zn2+ binding sites or generate ternary adduct, ProteomeZn-Sensor, with Zn2+
preferentially bound to proteome. Newport Green, for example, with its modest stability
constant (Kd  10-5 – 10-6 M) cannot efficiently compete with proteomic ligands to image mobile
Zn2+. It could not bind intracellular Zn2+ shuttled into LLC-PK1 cells using the ionophore,
pyrithione. Moreover, when proteomic Zn2+ was liberated by the reaction with sulfhydryl
binding reagents, NEM and diethylamine NONOate (DEA-NO), in the presence of Newport
Green, insignificant amount of Zn-NPG was detected. By contrast, the higher affinity Zn2+ sensor
iii

(Kd  0.7 nM) than Newport Green, ZP1 formed ternary adduct ProteomeZn-ZP1 with the
dynamic Zn2+, where Zn2+ is adventitiously bound to proteome’s high affinity zinc binding sites.
Besides with the mobile Zn2+, ZP1 also seems to react with the static distribution of cellular Zn 2+
in specific Zn-proteins and generates ZP1-Zn-Proteome ternary adduct. Therefore, the
effectiveness of the sensors to bind the cellular dynamic Zn 2+ is a variable of proteome’s Zn2+
binding characteristics.

iv
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1. INTRODUCTION
Living organisms require a number of metal ions to serve both as structural constituents and
catalytic cofactors in a wide range of proteins.1, 2 Among these biological metal ions, Zn2+ ranks
the second in terms of abundance, immediately following iron.3 Because of having a fully
occupied d-orbital (3d10), zinc does not participate in redox chemistry. Nevertheless, it has
been identified as an integral component in about 3,000 Zn-proteins, collectively known as Znproteome, which make up about 10% of the eukaryotic proteome.4, 5 Examples of proteins in
which Zn2+ serves as an important structural component include the most prevalent eukaryotic
transcription factors – the Zn-finger proteins, which bind DNA and in turn, regulate gene
expression.4,

6

Some of the well-known instances of enzymes containing Zn2+ as a catalytic

cofactor are carbonic anhydrase, alcohol dehydrogenase, alkaline phosphatase, and so on. In
these enzymes, Zn2+ can either act as a Lewis acid or help in holding the enzyme-substrate
complex together, and thus assists in catalytic conversion of the substrate into product. 7,

8

Typically, the thiolate, carboxylate and/or imidazole ligands from cysteine, aspartate and
histidine, respectively, bind Zn2+ occupying three coordination sites and thus leaving the fourth
binding site for the substrate or other molecules, including water.9 However, other possible
coordination numbers of Zn2+ in Zn-proteins have also been reported.4, 5, 10-12
Eukaryotic cells contain several hundred micromolar of Zn2+.13, 14 Almost all of this is bound to
proteins to make thousands of Zn-proteins.15 The concentration of steady-state cellular free or
labile Zn2+ falls in the range of picomolar to nanomolar.3, 13, 14, 16 Despite the extensive research
that has been carried out to understand the function of these thousands of Zn-proteins and the
1

role of Zn2+ in them, the mechanisms of Zn2+ trafficking that results in the generation of the
native Zn-proteins are still not well understood. Copper, another cellular trace metal ion, is
shuttled by different copper chaperon proteins to its target proteins.17-19 Copper trafficking
pathways may suggest that zinc is also transported by various not yet discovered zinc chaperon
proteins to find the target proteins. However, the important difference between copper and
zinc proteins is that there is only a handful of copper proteins in the cell, as opposed to ca. 3000
zinc proteins. To utilize the similar chaperone mediated pathway, Zn2+ will require perhaps
hundreds to thousands of chaperone proteins, which seems to be unlikely.

Figure 1.1 Hypothetical trafficking pathways of Zn2+ between and within cellular
compartments.

Figure 1.1 portrays a general model for Zn2+ trafficking pathways between the extracellular
medium and the cytosol or among the cellular compartments.20 One possible trafficking
pathway involves the binding of intracellular Zn2+ to apo-metallothionein, following the
2

transportation of Zn2+ - free or albumin bound (Zn-L) - into the cytosol from outside by
membrane Zn2+ transporters of the ZIP family, to form Zn-Metallothionein, which then serves as
a Zn2+ donor to apo Zn-proteins to generate specific Zn-proteins.20 An important cellular Znprotein, metallothionein (MT) can bind up to seven Zn2+ with high stability constants of 1011-12
per Zn2+ in two Zn-thiolate clusters.21-24 The fully saturated metallothionein, Zn7-MT displays
ligand substitution reactivity with apo-Zn-proteins such as carbonic anhydrase, which have
large stability constants for Zn2+ (log K = 11-12).24-26 This reactivity suggests that Znn (1-7)-MT can
serve as an intermediate along the way to form specific Zn-proteins (reactions 1 and 2).23, 24, 27,
28

n Zn2+ + apo-MT ⇌ Znn-MT

(1)

Znn-MT + n apo-PN ⇌ n Zn-PN + apo-MT

(2)

An alternative possible pathway is that Zn2+ transported into cytosol non-specifically binds to
proteins containing potential Zn2+ binding sites (Zn-L2 or Zn-L3), and through ligand substitution
is distributed randomly among different proteins of the proteome and small molecules such as
glutathione.20 Finally, as Zn-Lk encounters apo-Zn-protein (apo-PN), Zn2+ is transferred to
generate native Zn-proteins (Zn-PN) (reaction 3). Proteome’s non-specifically zinc binding
capacity has been reported in some recent studies.13, 29-33
Zn2+ + L2 ⇌ Zn-L2;

Zn-L2 + L3 ⇌ Zn-L3 + L2;

Zn-L3 + LK ⇌ Zn-LK + L3;

Zn-LK + PN ⇌ Zn-PN + LK

3

(3)

Moreover, the free Zn2+ pool resulting from the equilibrium between the randomly bound Zn2+
(Zn-LK) and the unbound Zn2+ can bind to apo-Zn-protein (PN) to generate specific Zn-proteins
(Zn-PN) (reaction 4).20 This free Zn2+ pool may also participate in cellular Zn2+ signaling.
Zn-LK ⇌ LK + Zn2+; Zn2+ + PN ⇌ Zn-PN

(4)

Apart from the roles of important structural and catalytic components in Zn-proteins, Zn2+ also
serves as an intracellular regulatory signal. The best studied example of Zn 2+’s role as a
regulatory signal in eukaryotic cells is the increased synthesis of metallothionein when the
intracellular concentration of Zn2+ is elevated.34, 35 The elevated concentration of intracellular
Zn2+ binds to apo-Zn-fingers of the metal response element (MRE) – binding transcription factor
1 (MTF-1), and thus changes its conformation such that it can bind the MRE sequences of the
promoter region of metallothionein and ZnT1 transporter genes (reaction 5).36-39 This
association, in turn, stimulates the synthesis of metallothionein and ZnT1 transporter mRNAs,
which then translate into apo-metallothionein and ZnT1 transporter proteins. Apometallothionein binds the cell’s increased level of Zn2+ and ZnT1 transporters efflux Zn2+ out of
the cell and thus, maintain the cellular zinc homeostasis.40
MTF-1 inactive + n Zn2+ ⇌ Znn (1-6)-MTF-1active
Znn-MTF-1 + MRE ⇌ Znn-MTF-1•MRE

(5)

Moreover, various studies have reported the participation of Zn2+ in dyanamic cellular signaling
processes such as synaptic chemical transmission and endocrine signaling.41,

42

Abundant in

synaptic vesicles of glutamatergic neurons, Zn2+ is released into the synaptic cleft following

4

neuronal stimulation.43-45 However, the exact mechanism of how it serves as a signaling agent is
yet to understand.
The cellular roles of Zn2+ as a regulatory signal and a chemical messenger in neuronal synapses
clearly suggest that it is not only bound to fixed binding sites in various Zn-proteins as structural
and catalytic constituents. Rather, cells have a transient concentration of mobile or free Zn2+
generated by some stimulus, which in turn participates in cellular signaling. 46 The generation of
this dyanamic Zn2+ pool can be shown by the following equation:
Zn-L + stimulus ⇌ Zn2+ + L

(6)

L represents Zn2+ binding ligands, including Zn-protein and small molecules such as glutathione.
Following the revelation of the transient mobile Zn 2+ pool and its function in cellular signaling,
the biochemical studies of Zn2+ metabolism has gained a new momentum. This required the
discovery of some analytical tool to study the cellular functions of this dynamic Zn 2+ pool. As
yet, zinc fluorescent sensors have been considered the best analytical tool for this purpose.
Over the past couple of decades, a number of fluorescent sensors with a wide variety of
structures, stability constants ranging from micromolar to nanomolar, excitation wavelength
(350 – 550 nm) and emission wavelength (450 – 600 nm) have been designed and synthesized
to image the mobile Zn2+ pool of the cells.1, 2, 47-49 The structures of these fluorescent sensors
contain a fluorophore reporter linked with the Zn2+ chelating ligand. Upon Zn2+ binding, sensors
display an enhancement of fluorescence through photo-induced electron transfer (PET)
quenching mechanism.1, 2 According to this mechanism, in the absence of Zn 2+ ion, the electron
rich receptor (chelating ligand) quenches the fluorescence of the fluorophore. As Zn 2+ binds to
5

the receptor and thus prevents its interference in fluorescence emission, an enhancement of
emission is followed.1, 2

Figure 1.2 Examples of some commonly used fluorescent sensors to image cellular Zn 2+.

In typical experiments aimed at studying the dynamic cellular Zn2+ using fluorescent sensors,
cells are incubated with the cell-permeable ester form of the sensor molecule (e.g. Zinquin,
Newport Green, FluoZin-3 etc.), which following its entry into the cell gets cleaved by cellular
esterases into its negatively charged acid form and thus becomes trapped inside the cell. 50

6

However, some sensors (e.g. TSQ, Zinpyr-1) are charge neutral and can permeate the cell
membrane, and thus their ester forms are not required for cellular use. Upon influx into the
cell, the fluorescence enhancement and its reversal by the introduction of a cell permeable
strong Zn2+ chelator, typically N, N, N’, N’-tetrakis (2-pyridylmethyl) ethane-1, 2-diamine (TPENstructure in Figure 1.2), are attributed to the imaging of free or labile Zn 2+.46 The sensing of free
Zn2+ pool generated by the equation (6) by the fluorescent sensor and its chelation by TPEN can
be displayed by the following equations:
Zn2+ + Sensor ⇌ Zn-Sensor
Zn-Sensor + TPEN ⇌ Zn-TPEN + Sensor

(7)
(8)

The discovery of these fluorescent sensors has boosted the biochemical research of zinc
metabolism, which, in turn, has revealed further evidence of the role of Zn2+ as a regulatory
signal and secondary messenger. For example, an enhancement of a Zn2+ sensor fluorescence in
brain injury models has led to the conclusion that labile or chelatable Zn 2+ plays a crucial role in
neurodegenerative diseases.51-53 In another study, pulmonary endothelial cells were exposed to
nitric oxide or lipopolysaccharide in the presence of a zinc sensor that resulted in an increase of
zinc sensor fluorescence signal, which suggested that Zn 2+ participates in cellular signaling
pathways that result in airway constriction.54-56
Although the in vitro application of these fluorescent sensors to bind free Zn2+ is simple, their
cellular use to image labile Zn2+ pool might be complicated due to a number of factors. Firstly,
for quantitative measurement of free or competitively bound Zn 2+ using these sensors, the
stability constant of the sensor must be within the range of cellular free Zn 2+ concentration or
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similar to that of competing ligands for bound Zn2+. Moreover, in case of sensors with relatively
high stability constants compared with cellular Zn2+ pools (ZnLk, Fig. 1.1) or with large
intracellular concentration, the sensor might itself react with the bound Zn 2+ pool of the cell
and therefore, disturb the equilibrium between the Zn 2+ bound to different ligands and free
Zn2+ (reaction 5). Another possible unwanted reaction is that the sensor might directly chelate
Zn2+ out of native Zn2+ binding sites (proteins or small molecules) (reaction 9). Both cases give
rise to fluorescence enhancement, which may confuse the researchers with the fluorescence
due to imaging of mobile Zn2+.
Zn-Ligand + Sensor ⇌ Ligand + Zn-Sensor

(9)

A significant number of studies have been done over the past two decades that used these
fluorescent sensors to detect the mobile Zn2+ in cells.49, 57-63 However, the key drawback of most
of these studies is that they relied mostly on fluorescent micrographs obtained following the
incubation of cells with the sensor using a fluorescence microscope to draw their conclusions.
Not much of the chemistry that occurs between the sensor and the cellular constituents has
been investigated. The sole dependence on the fluorescence observation through a
microscope, therefore, may often give misleading results. For example, 6-methoxy-8-ptoluenesulfonamido-quinoline (TSQ) and its derivative Zinquin (ZQ) are two quinolone-based
fluorophores commonly used by the researchers to image cellular free or labile Zn 2+ pool.49, 57,
61, 64

These fluorophores use their bidentate ligands comprised of quinoline and sulfonamide

nitrogens to bind Zn2+ in a 2:1 stoichiometry (Figure 1.2).50, 65 Although structurally similar to
TSQ, the presence of a methyl group at the 2 position enhances Zinquin’s affinity for Zn 2+
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(Figure 1.2), and therefore it can sense smaller intracellular Zn2+ concentration than TSQ.50 The
fluorescence increase upon their treatment with cells has naively been attributed to their
binding of Zn2+ to from fluorescent species Zn(TSQ)2 or Zn(ZQ)2. However, Meeusen et al. and
Nowakowski et al. have shown that when used in cells, both TSQ and Zinquin actually image a
subset of Zn-proteins, not free Zn2+ as various studies claimed, through the formation of the
ternary adduct, TSQ-Zn-Protein or Zinquin-Zn-Protein.50, 65, 66 This subset of Zn-proteins imaged
by TSQ or ZQ represents about 15-20% of the Zn-proteome. The generation of this ternary
adduct species is quite evident from its different spectral properties. Zn(TSQ/ZQ) 2 complex
displays an emission maximum of 490 nm when excited at 370 nm, whereas (TSQ/ZQ)-ZnProtein ternary adduct gives a blue-shifted 470 nm emission. As Zinquin binds Zn2+ with higher
affinity than TSQ, along with ZQ-Zn-Protein ternary adduct formation, it also may react with Znproteome to generate Zn(ZQ)2 complex.50 Like of Zn(TSQ/ZQ)2, the fluorescence of (TSQ/ZQ)Zn-Protein ternary adduct is also readily reversed by the reaction with the strong Zn 2+ chelator
TPEN. Meeusen et al. have also demonstrated that other than chelating Zn 2+ out of the ternary
adduct as Zn-TPEN, TPEN, itself can also form ternary adduct TPEN-Zn-Protein by replacing the
sensor.67
2 Zn2+ + TSQ/ZQ ⇌ Zn(TSQ/ZQ)2

(emission, max  490 nm)

TSQ/ZQ + Zn-Protein ⇌ (TSQ/ZQ)-Zn-Protein

(emission, max  470 nm)

2 ZQ + Zn-Protein ⇌ Zn(ZQ)2 + apo-Protein

(11)

(12)

(TSQ/ZQ)-Zn-Protein + TPEN ⇌ Zn-TPEN + TSQ/ZQ + apo-Protein
(TSQ/ZQ)-Zn-Protein + TPEN ⇌ TPEN-Zn-Protein + TSQ/ZQ

9

(10)

(13)
(14)

This finding further deepens the question of what various sensors actually image at the cellular
level. The present study has examined the chemical and biological properties of Newport
Green, a fluorescent Zn2+ sensor with modest binding constant (Kd  10-5 – 10-6 M) and its
efficiency as a zinc sensor within the cellular framework. To compare with Newport Green
results, a relatively higher affinity sensor, Zinpyr-1, with the binding constant of 0.7 nM has also
been studied. Furthermore, having found that TSQ and Zinquin bind Zn-proteins to form ternary
adducts (TSQ/Zinquin)-Zn-Protein, this study has investigated how TSQ, Zinquin and FluoZin-3
interact with proteome incubated with diethylamine NONOate (DEA-NO). This nitric oxide (NO)
donor spontaneously releases NO at physiological pH, which in turn reacts with proteomic
sulfhydryl groups to induce the liberation of Zn2+ from native Zn-proteins. One of the key
findings of these studies was that aside from the native Zn 2+ binding sites of Zn-proteins,
proteome possesses a good number of high affinity Zn 2+ binding sites. Therefore, we next
examined the proteomic components involved in these high affinity Zn 2+ binding. Finally, the
hypothesis that cells synthesize varied concentration of Zn-proteome at different phases of the
cell cycle, which can explain the asymmetric distribution of fluorescence among neighboring
LLC-PK1 cells observed by Meeusen et al. following the incubation of cells with TSQ, was
investigated.
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2. MATERIALS AND METHODS
2.1 Chemicals and Reagents
The zinc fluorescent sensors Newport Green, DCF diacetate (NPGE) and Newport Green
dipotassium salt (NPGA) were purchased from Invitrogen, TSQ from AnaSpec, Inc., Zinquin –
both acid and ethyl ester - from Enzo Life Sciences, FluoZin-3 from Molecular Probes, and
Zinpyr-1 (ZP1) from Santa Cruz Biotechnology. All these zinc sensors were dissolved in DMSO
and stored in the dark at -200 C in small aliquots. Diethylamine NONOate (DEA-NO) was
obtained from Cayman Chemical. DEA-NO was dissolved in 0.01 M NaOH and stored in aliquots
at -800 C until use. N-ethylmaleimide (NEM), nocodazole and thymidine were bought from
Sigma. All the other chemicals and reagents were purchased from either Fisher Scientific or
Sigma-Aldrich at the highest grade available.
The model zinc proteins alcohol dehydrogenase and carbonic anhydrase were obtained from
Sigma in the form of lyophilized powder. The powders were dissolved in degassed 20 mM Tris
adjusted to pH 7.4 and stored at -800 C. The antibiotics penicillin G and streptomycin sulfate for
cell culture were purchased from Fisher Scientific and Sigma, respectively. Fetal calf serum (FCS)
was also bought from Fisher Scientific and stored at -800 C until use.
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2.2 Cell Culture
2.2.1. Preparation of medium and solutions
Both LLC-PK1 (pig kidney cells) cell line (adherent cell line) and CCRF-CEM human lymphocytic
leukemia cells (suspension cell line) were purchased from ATCC and were grown in Medium 199
with HEPES modification and RPMI 1640 medium, respectively. Medium powder from the
bottle was dissolved in 1L MilliQ water. 2.2 g (for Medium 199) or 2.0 g (for RPMI 1640) sodium
bicarbonate (NaHCO3) was added to the medium solution and the pH of the solution was
adjusted to 7.2. The medium was then supplemented with 50 mg/L penicillin G and 50 mg/L
streptomycin sulfate, and sterile filtered before use.
Confluent LLC-PK1 cells were released from the culture flask by 10X trypsin-EDTA treatment. To
prepare 200 mL 10X trypsin-EDTA solution, 1.0 g trypsin, 0.4 g EDTA tetrasodium salt and 1.8 g
sodium chloride (NaCl) were dissolved in MilliQ water. The solution was sterile filtered and
stored in 10 mL-aliquot at -200 C.

2.2.2. Cell culture
LLC-PK1 cells were grown in Medium 199 with HEPES modification supplemented with 2.2 g/L
NaHCO3, 50 mg/L penicillin G, 50 mg/L streptomycin and 4% fetal calf serum (FCS) (from Fischer
Scientific). Each flask of cells contained 15 mL of media mix. The cells were incubated at 370 C in
the presence of 5% CO2. The media was changed every 2-3 days until confluence. At the point
of confluence, old media was discarded completely and cells were released by 10X trypsin-EDTA
solution for 10-15 min in the incubator. Once the cells were released, 0.1-0.2 mL cell
12

suspension was used to make new culture flask and the remaining cells were used for growing
cells in 100-mm culture plates. Each plate contained 10 mL of media mix and 0.4 mL of FCS
along with cells.
CCRF-CEM human lymphocytic leukemia cells were cultured in suspension (0.5  106 to 1.0 
106 cells per mL) in RPMI 1640 medium supplemented with 10% FCS. Once the cell density
reached to 0.5 – 1.0 x 106 cells per mL, cells were subdivided by dilution in new media (CCRFCEM).

2.3 Synchronization of CCRF-CEM cells at G1 and G2/M phases
To synchronize CCRF-CEM cells at G1 phase, cells were grown in RPMI medium supplemented
with 2.0 g/L NaHCO3, 50 mg/mL penicillin, 50 mg/L streptomycin and 10% fetal calf serum (FCS).
When the cell density reached about 5.0 x 105 cells per mL, 2.0 mM thymidine was added to
each plate of cells. Prior use, thymidine was dissolved in purified MilliQ water and the solution
was then sterile filtered. The cells were incubated with 2.0 mM thymidine for 24 hours.
Following the incubation, the cell synchronization at G1 phase was confirmed using Flow
Cytometry.
To block CCRF-CEM cells at G2/M phase, each plate of cells was incubated with 100 ng/mL
nocodazole after the cell density reached 5.0 x 10 5 cells per mL. Following 24 hours of
incubation, cells were sorted using a flow cytometer to confirm the synchronization at G2/M
phase.

13

2.4 Cell counting
LLC-PK1 and CCRF-CEM cells were counted using a hemacytometer. In case of LLC-PK1 cells, the
culture medium from one plate of confluent of cells (ca. 107 cells) was discarded and the cells
were then incubated with 450 µL of 10X trypsin-EDTA solution for 10-15 min at 370 C. 1 mL of
DPBS was added to the released cells following trypsin-EDTA incubation. Cells were then
transferred to a centrifuge tube containing 550 µL horse serum to make the final volume of 2
mL (450 µL trypsin-EDTA + 1 mL DPBS + 550 µL horse serum) and mixed very well. 10 µL of cells
was then transferred to an eppendorf tube and diluted to 100 µL using DPBS. 10 µL from the
final cell suspension was placed onto a hemacytometer and the cells were counted. The
counted number was finally multiplied by the dilution factor and the actual number of cells
determined.
For counting CCRF-CEM cells, cells suspended in RPMI media from one plate were transferred
to a centrifuge tube and mixed very well by inverting the tube. 10 µL of cell suspension was
then placed onto a hemacytometer and the cells were counted.

2.5 Cell viability assay (Trypan blue exclusion assay)
2.5.1 Cell viability of LLC-PK1 cells incubated with Newport Green ester (NPGE)
The culture medium of one plate of LLC-PK1 cells containing 107 cells was completely drained
off and the cells were incubated with 1 mL of 10X trypsin-EDTA solution for 10-15 min. The
released cells were collected in a centrifuge tube and washed three times with fresh DPBS and
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finally resuspended in DPBS. Cells were then incubated with 10 µM NPGE for an hour at 25 0C.
One hour later, 104 cells were reacted with 0.4% Trypan Blue solution in 1:1 ratio and viable
cells were counted immediately using a hemacytometer. Trypan blue is a dye which can
penetrate the compromised cell membrane of a dead cell and the cell will in turn look blue
under the hemacytometer, while the living cells will appear colorless as Trypan blue is not able
to permeate through the cell membrane of an intact cell.68-70 The cell viability assay was also
used with LLC-PK1 cells suspended in culture medium.

2.5.2 Cell viability assay of CCRF-CEM cells blocked at G1 and G2/M phases
Following 24 hours of incubation of CCRF-CEM cells with 2 mM thymidine or 100 ng/mL
nocodazole, 10 µL cell suspension was taken in an Eppendorf tube and was mixed with 10 µL
0.4% Trypan Blue solution. The viable cells were counted immediately using a hemacytometer.
Trypan blue exclusion assay was also performed for control cells, which were treated with
neither thymidine nor nocodazole.

2.6 Flow cytometry of CCRF-CEM cells blocked at G1 and G2/M phases
CCRF-CEM cells were incubated with 2 mM thymidine or 100 ng/mL nocodazole for 24 hours.
Following incubation, synchronized and control (untreated) cells were transferred to centrifuge
tubes, spun down and the extracellular medium was discarded. Cells were then washed twice
with Flow Cytometry staining buffer (FACS buffer) prepared by mixing Dulbecco’s phosphate
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buffered saline (DPBS), 5% fetal calf serum (FCS) and 0.1% sodium azide. Cells were
resuspended in 70% ethanol while vortexing tube and stored at -200 C. On the day of run,
stored cells were pelleted for 10 min at 3400 rpm, washed twice with FACS buffer and
resuspended in 500 µL FACS buffer. In order to eliminate the staining of double stranded RNA
(dsRNA), 500 µg/mL RNase A was added to the cells. Cells were then incubated for 20 min at
room temperature. After incubation, cells were again pelleted and resuspended in 500 µL FACS
buffer. Prior to running cells on flow cytometer, 10 µL of 4’,6’-diamidino-2-phenylindole (DAPI)
from 1 mg/mL stock solution (in DMF) was added to both control and synchronized cells. Flow
cytometry of the cells was performed on a BD FACSAria III, DIVA version 6.1.3.

2.7 Fluorescence Spectroscopy of LLC-PK1 Cells
2.7.1 Fluorescence spectroscopy of LLC-PK1 cells incubated with Newport Green ester (NPGE)
Cultured cells were grown in 100-mm culture plates until confluence was attained. Culture
media was discarded and the plates washed three times with cold cholate buffer, prepared by
dissolving 2.47 g Na2HPO4, 0.53 g NaH2PO4, 17.0 g NaCl and 13.33 g choline chloride in 2 L
MilliQ water. Cells were then gently scraped from the plates with a rubber cell scraper and
pooled in Dulbecco’s phosphate buffered saline (DPBS) (0.1 g/L MgCl 2.6H2O, 0.2 g/L KCl, 0.2 g/L
KH2PO4, 8.0 g/L NaCl, 1.15 g/L anhydrous Na2HPO4). Cells were collected by centrifugation at
680 g for 5 min and resuspended in 10 mL DPBS. The cell suspension was then transferred to a
cuvette and treated with 10 µM Newport Green ester (NPGE) and incubated in the dark for one
hour at 25 0C. For comparison, experiments were also conducted at 37 o C. Then, over a 45 min
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period and using an excitation wavelength of 505 nm, emission spectra were recorded between
515 nm and 600 nm with a Hitachi F-4500 fluorescence spectrophotometer. Afterwards, 10 µM
N,N,N',N'-tetrakis(2-pyridylmethyl)ethane-1,2-diamine (TPEN) was added and the fluorescence
spectrum monitored for another 15 min. Finally, the reaction mixture was centrifuged using a
microcentrifuge for about 1 min at 290 g to separate the extracellular medium and the cells,
followed by resuspension of the cells in 1 mL DPBS.

2.7.2 Fluorescence spectroscopy of LLC-PK1 cells incubated with Zinpyr-1 (ZP1)
Harvested LLC-PK1 cells were suspended in DPBS and an aliquot of 1 mL cell suspension (ca. 10 7
cells) was transferred to a cuvette. Cells were then incubated with 10 µM ZP1 for 15 min. Using
an excitation wavelength of 515 nm, emission spectra were recorded between 520 nm and 600
nm. Subsequently, 30 µM TPEN was added for 15 min and fluorescence spectrum observed. In a
separate experiment, 30 µM ethylenediaminetetraacetate (EDTA) was added to cells for 15 min
following incubation with 10 µM ZP1 for 15 min.

2.7.3 Fluorescence spectroscopy of LLC-PK1 cells incubated with Zinquin or TSQ followed by
diethylamine NONOate (DEA-NO)
LLC-PK1 cells were harvested and resuspended in DPBS. An aliquot of 1 mL cell suspension (ca.
107 cells) was placed in a cuvette and treated with 20 µM Zinquin ethyl ester or TSQ and
incubated for 30 min at 25 0C followed by 500 µM DEA-NO for another 25 min. Using an
excitation wavelength of 370 nm, emission spectra were recorded between 400 nm and 600
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nm. Afterwards, 10 µM TPEN was added and the fluorescence spectrum monitored for another
10 min.
2.7.4 Fluorescence spectroscopy of CCRF-CEM cells synchronized in G1 phase incubated with
TSQ or Zinquin
Cultured CCRF-CEM cells were grown in 100-mm culture plates. When the cell density reached
about 5.0 x 105 cells per mL, 2 mM thymidine was added to each plate. Following 24 hours of
incubation, cells suspended in RPMI medium were transferred from culture plates to a 50-mL
centrifuge tube. Cells were then spun down and the medium discarded. Cells were washed
twice with DPBS and finally resuspended in fresh DPBS. An aliquot of 1 mL cell suspension (ca.
1-2 x 107 cells) was placed in a cuvette and treated with 20 µM TSQ or Zinquin for 20-25 min at
250 C. Using an excitation wavelength of 370 nm, emission spectra of the cell suspension were
recorded between 400 nm and 600 nm. The protocol was repeated for the control experiment,
namely, fluorescence spectroscopy of untreated cells with TSQ or Zinquin.

2.8 Isolation of cell lysate following incubation of cells with sensor (and DEANO) and its fractionation using gel filtration column or Centricon filtration
2.8.1 Preparation of Sephadex G-75 gel filtration column
Sephadex G-75 beads (4-5 g per gel filtration column) purchased from GE Healthcare were
soaked in 20 mM Tris buffer (pH 7.4) for 24 hours. Following on, soaked beads were degassed
for an hour and then slowly packed in glass columns to make 0.7 cm x 80 cm Sephadex G-75 gel
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filtration columns. Columns were washed with degassed 20 mM Tris buffer (pH 7.4) each time
before use.
2.8.2 Isolation of cell lysate following incubation of cells with sensor (and DEA-NO)
Following incubation of LLC-PK1 or CCRF-CEM (control or synchronized) cells with NPGE or ZP1
or ZQ/TSQ  DEA-NO, cell suspensions were centrifuged at 640 g to separate the pellet from
the extracellular medium and to remove extracellular sensors. Cells were further washed twice
with fresh DPBS to get rid of any residual extracellular sensors. The last cell pellet was
resuspended in 1 mL of cold MilliQ water. Cells were then lysed by sonication and centrifuged
at 47,000 g for 20 min at 4o C to collect the cell supernatant or cell lysate.

2.8.3 Fractionation of the cell lysate using Sephadex G-75 gel filtration column or Centricon
filtration
The cell lysate collected as above was either loaded onto an 80 cm  0.75 cm gel filtration
column of Sephadex G-75 (GE Healthcare) equilibrated with 20 mM Tris buffer (pH 7.4) at room
temperature or filtered through a Millipore Centricon Centrifuge filter (3K MW cut off) at 4 o C
by centrifugation at 13000 rpm for 30 min to separate the high and low molecular weight
fractions. During gel-filtration chromatography, the column was eluted with degassed 20 mM
Tris-Cl (pH 7.4) and ninety (for NPGE incubated cells) or sixty (for ZP1 or TSQ or ZQ incubated
cells) fractions were collected. Emission spectra of all fractions were obtained as described
above. The zinc content in each fraction was also detected by flame atomic absorption
spectroscopy (AAS).
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2.9 Isolation of Proteome Using Sephadex G-75 Chromatography
LLC-PK1 or CCRF-CEM cells were harvested as described above and finally resuspended in 1 mL
cold MilliQ water. Cells were then lysed by sonication and centrifuged at 47,000 g for 20 min to
collect the cell supernatant, which was then loaded onto a Sephadex G-75 column equilibrated
with degassed 20 mM Tris buffer (pH 7.4). The supernatant was eluted with degassed 20 mM
Tris-Cl (pH 7.4) and 1 mL fractions were collected. Fractions within the high molecular weight
region having absorbance at 280 nm were pooled. These pooled fractions were referred to as
the proteome. Proteome was stored in 1 mL aliquots at -800 C until use. On the day of
experiment, proteome was slow ice-thawed.

2.10 Reaction of isolated proteome with fluorescent sensors
Frozen proteome was ice-thawed and transferred to a cuvette. Proteome was then incubated
with the fluorescent sensor (NPG, ZP1, TSQ, Zinquin, FluoZin-3) for a certain time depending on
the type of sensor. The progress of the reaction was monitored by recording emission spectrum
at a certain time interval. Upon completion of the reaction, the final reaction mixture was
fractionated using either Sephadex G-75 gel filtration column or Centricon filtration in order to
determine the location of the fluorescent species. In case of Sephadex G-75 gel filtration, the
sample was eluted with degassed 20 mM Tris buffer (pH 7.4) and sixty fractions were collected.
All the fractions were analyzed for both fluorescence, and zinc content using flame atomic
absorption spectrophotometry.
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2.11 BioRad DC Protein Assay
The protein concentration was measured using a BioRad DC Protein Assay kit; 2.0 mg/mL
bovine serum albumin (BSA) served as the standard. Prior to the measurement of the sample
protein concentration, a calibration curve was made using six standard protein concentrations
ranging from 2.0 mg/mL to 0.0625 mg/mL prepared by serial dilution. 25 µL of each of the
standards and a blank (Tris buffer only) were mixed with 125 µL alkaline copper tartarate and 1
mL dilute Folin reagent.71, 72 Upon mixing, the solutions were then incubated for 15 min at room
temperature. Following incubation, the absorbance at 750 nm of each of the standards and
blank was recorded using a UV-Visible spectrophotometer. The absorbance at 750 nm was
plotted against the concentrations of the standards to make the calibration curve. To measure
the concentration of the protein sample, the above mentioned protocol was followed and the
recorded absorbance was compared with the calibration curve.

2.12 Isolation of subcellular proteomes from LLC-PK1 cells
Subcellular proteomes were isolated as described with modifications.73 LLC-PK1 cells were
collected and resuspended in 4 mL of pre-chilled homogenation buffer (0.25 M sucrose, 15 mM
KCl, 1.5 mM MgSO4, and 10 mM Tris-Cl pH 7.4). The cell suspension was then homogenized
using a pestle and centrifuged at 1,000 g for 10 min at 4 o C.

The pellet was saved as the

nominal membrane-nuclear fraction. Supernatant was then centrifuged at 10,000 g for 15 min
at 4o C. The pellet was retained as the mitochondrial fraction. Supernatant was centrifuged
again at 100,000 g at 4o C and the resultant supernatant was designated the cytosolic
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proteome. The membrane-nuclear and mitochondrial fractions were sonicated and centrifuged
at 47,000 g for 20 min at 4

0

C and the resultant supernatants were labelled as

‘membrane/nuclear and mitochondrial proteomes, respectively. The protein concentrations of
all three fractions were measured using BioRad DC protein assay. Subcellular proteome samples
were stored at -800 C, if not used immediately after isolation. On the day of experiment, the
frozen samples were slowly ice-thawed.

2.13 Reaction of LLC-PK1 cells with Zn(pyrithione)2 in the presence of Newport
Green (NPGE)
Harvested and washed LLC-PK1 cells were resuspended in 1 mL DPBS and transferred to a
cuvette. Cells were then incubated with 10 µM NPGE for 30 min while monitoring the progress
of the reaction by recording the emission spectrum. 30 min later, the cell suspension was
centrifuged at 640 g for 5 min and the supernatant was discarded. The cell pellet was washed
twice with DPBS to remove any residual extracellular NPG and resuspended in 1 mL DPBS.
Following wash, the emission spectrum of the cell suspension was recorded for another 10 min.
Cells were then reacted with a pre-incubated mixture of 10 µM ZnCl2 and 2 µM pyrithione for
20 min. Change of fluorescence was recorded upon addition of Zn(pyrithione) 2. Subsequently,
10 µM EDTA was added for 10 min followed by 10 µM TPEN for another 10 min.
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2.14 Reaction of model Zn-proteins (alcohol dehydrogenase, carbonic
anhydrase) with Newport Green or Zinpyr-1
The solutions of the model Zn-proteins, such as alcohol dehydrogenase and carbonic
anhydrase, were prepared by dissolving the lyophilized powder of the Zn-proteins in degassed
20 mM Tris buffer (pH 7.4). The zinc concentration of the protein solutions were measured
using flame AAS. Zn-protein solutions were incubated with Newport Green (acid or ester) or
Znpyr-1 and the progress of the reaction was monitored by recording emission spectrum. To
identify the fluorescent species, the final reaction mixture was fractionated using either
Sephadex G-75 gel filtration column or Centricon filtration. For Sephadex G-75 gel filtration, the
sample was eluted with degassed 20 mM Tris buffer (pH 7.4) and 50-60 fractions were
collected. All the fractions were analyzed for both fluorescence, and zinc content using flame
atomic absorption spectrophotometry.

2.15 Quantification of Zn2+ by Atomic Absorption Spectrophotometry
The concentration of Zn2+ in solutions was determined by flame Atomic Absorption
Spectrophotometry (AAS). A GBC model 904 instrument employed an acetylene torch to
atomize samples using an 80:20 mixture of compressed air and acetylene. Zinc measurements
were made with deuterium background correction. The instrument was calibrated before each
run using three standard Zn2+ solutions of 0.5 ppm, 1.0 ppm and 2.0 ppm. The calibration curve
was not considered acceptable until the maximum error was 0.2 µM or less.
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2.16 Quantification of sulfhydryl groups in proteome
The concentration of sulfhydryl groups was determined with Ellman’s Reagent or 5, 5’-dithiobis2-nitrobenzoic acid (DTNB).74 To prepare a 10 mM DTNB stock solution, 25 mL MilliQ water was
added to 0.1 g DTNB solid. The mixture was gently stirred. Because DTNB is insoluble at acid pH
but oxidizes immediately at pH greater than 8.0, the pH of the solution was monitored while
being stirred. Since the pH was around 3.0 to start out and little DTNB powder was in solution, a
few crystals of Trizma (Tris) base was added until the pH was between 6.5 and 7.0. The solution
was then filtered to remove the residual amount of undissolved DTNB. The filtered DTNB
solution was kept into a small brown bottle and stored in dark. The color of the solution was
pale yellow.
For measurement of sulfhydryl concentrations of proteome samples, 60 µL of proteome
sample was diluted with 540 µL 20 mM Tris-Cl, pH 7.4. 60 µL of 10 mM DTNB was then added to
the sample and vortexed immediately. The solution was incubated in dark for 30-60 min before
the absorbance at 412 nm was obtained. An extinction coefficient of 13,600 cm-1M-1 was used
to determine the concentration of reactive thiol groups in the samples.
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3. RESULTS
3.1 Chemical Biology of Newport Green (NPG)
Newport Green (NPG) is a fluorescent zinc sensor with relatively low stability constant for Zn2+
(Kd  10-5 – 10-6 M).1, 46 A number of studies have used this sensor to image intracellular mobile
Zn2+ and revealed various physiological roles of Zn2+ based on the spectral properties of
Newport Green.75-80 Upon binding Zn2+, NPG displays an enhancement of fluorescence at 530
nm. Typically, the fluorescence enhancement following the incubation of cells with NPG is
linked with the intracellular Zn-NPG formation (reaction 3.1). However, the possibilities of other
reactions of NPG with the cellular constituents are often ignored. For example, like TSQ and
Zinquin, NPG may react with cellular Zn-proteins to generate ternary adduct species NPG-ZnProtein (reaction 3.2).23, 65
Zn2+ + NPG ⇌ Zn-NPG

(3.1)

Zn-Protein + NPG ⇌ NPG-Zn-Protein

(3.2)

Moreover, due to its low stability constant for Zn 2+, NPG may have to compete with other
potential cellular ligands for Zn2+, including proteome and small molecules. Therefore, its ability
to effectively image intracellular Zn2+ will depend on the stability of Zn-NPG in the presence of
other cellular competitors of Zn2+. This present work examines how effectively NPG can serve as
an intracellular zinc sensor.
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3.1.1. Spectral properties of NPG and Zn-NPG
The ester form of Newport Green, NPGE, does not fluoresce but gains its fluorescent property
upon conversion to its acid form, NPGA, catalyzed by cellular esterase. With excitation at 505
nm, NPGA emitted fluorescence with a wavelength maximum at 530 nm. However, the
fluorescence of NPGA and Zn-NPGA were not linearly dependent on their concentration (Figure
3.1.1). With increasing concentration, their fluorescence intensity increased non-linearly until a
maximum value after which it declined.

Moreover, the emission wavelength maximum

changed with concentration. The declining fluorescence intensity of NPG A and Zn-NPGA at
higher concentration might be due to the stacking of fluorescein, the reporter part of NPG.
Regardless of the cause, this property of NPGA makes it difficult to quantify the actual Zn2+
concentration simply from the observation of its fluorescence response. When titrated with
Zn2+, NPGA formed a 1:1 complex with its emission wavelength maximum unaltered and about
twice the intensity of the free ligand (Figure 3.1.2 and 3.1.3). The product rapidly reacted with
TPEN, a cell permeant, high affinity chelator of Zn 2+, returning the fluorescence to that of NPGA
(Figure 3.1.3).

3.1.2. Cell viability
As the cellular experiments in this study were performed in DPBS buffer at 25 0C for an hour or
so, the cell viability was determined under such conditions using the Trypan Blue exclusion
assay. Cell viability under experimental conditions was calculated to be 90%, whereas cells kept
in complete culture medium were found to be almost 100% viable.
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Figure 3.1.1 Change of fluorescence intensity and emission wavelength maximum of NPG A
and Zn-NPGA with increasing concentration: Equivalent amounts of NPGA and ZnCl2 were mixed
to make Zn-NPG complex. The numbers under each data point indicate the emission
wavelength maximum of each spectrum in nanometers.
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Figure 3.1.2 Titration of NPG with Zn2+: 10 µM NPGA in 20 mM Tris (pH 7.4) was titrated with
the increasing concentration of ZnCl2 at 25o C. Following each addition of ZnCl2, the sample was
excited at 505 nm and fluorescence spectrum was read in the range of 515 – 600 nm. The
maximum fluorescence intensity of each titration point was plotted against the total
concentration of the added Zn2+.
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Figure 3.1.3 Fluorescence spectra of NPG, Zn-NPG and the quenching by TPEN: 10 µM NPGA in
20 mM Tris (pH 7.4) was incubated with 10 µM ZnCl2 at 25o C. Subsequently, 10 µM TPEN was
added to the solution. The sample was excited at 505 nm and the fluorescence spectra were
read in the range of 515 – 600 nm.
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3.1.3 Reaction of NPGE with LLC-PK1 cells
As a basis for addressing the question of what NPG images in cells, the reaction of NPGE with
107 LLC-PK1 cells in DPBS buffer was monitored by spectrofluorimetry at 25 o and 37o C. At 25oC,
fluorescence intensity increased slowly at 530 nm, reaching a maximum after 40 min, indicative
at least of the conversion of some NPGE to NPGA catalyzed by cellular esterases (Figure 3.1.4).
The background fluorescence of media and cells was insignificant in comparison with the
fluorescence contributed by the formation of NPGA (Figure 3.1.5B). Considering the initial
extracellular concentration of NPGE, complete hydrolysis of the sensor would result in an
intensity of about 5000 arbitrary units. Since the observed, maximal fluorescence was only
about 1200 units, at most about 25% of NPGE had undergone reaction during this period. At
that point, TPEN was added to quench the fluorescence of any Zn-NPGA that had formed. No
reduction in fluorescence emission was observed over a period of 20 min, leading to the
conclusion that detectable Zn-NPGA had not been produced in these cells. Since TPEN forms
ternary adducts with Zn-proteins, the results also suggested that NPGA had not formed NPG-Znprotein species that could be converted to TPEN-Zn-proteins.67
The reaction of NPGE with 107 LLC-PK1 cells at 37 oC was qualitatively similar to the one at 25o C
though as expected it proceeded at a faster rate (Figure 3.1.4). Moreover, treatment of cells
with TPEN prior to addition of NPGE failed to modify the reaction, confirming the lack of
interaction of NPG with intracellular Zn2+. Although the formation of Zn-NPGA was not
supported at either temperature, it remained possible that ternary adducts of NPGA-Znproteins accounted for some of the fluorescence increase, and were unreactive with TPEN.
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Figure 3.1.4 Reaction of LLC-PK1 cells with NPGE. 107 LLC-PK1 cells suspended in 1 mL DPBS
were treated with 10 µM NPGE for 40 min at 25oC. Subsequently, 10 µM TPEN was added for
another 20 min. The reaction was repeated at 37oC. In the third case, 107 LLC-PK1 cells were
pre-incubated 10 µM TPEN for 20 min at 25oC followed by the treatment with 10 µM NPGE for
another 40 min.
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After the reaction, the cell suspension was centrifuged to separate the extracellular medium
and cells, which were then resuspended in DPBS. Surprisingly, most of the fluorescence (about
70%) was found in the external medium (Figure 3.1.5A), and it could not be quenched by the
addition of 10 µM TPEN for 5 min (Figure 3.1.6). To investigate this surprising result, 2.7  107
cells/mL were incubated with 10 µM NPGE in DPBS at 25 oC for 40 min followed by fluorescence
emission analysis. The suspension (1) was centrifuged to produce extracellular supernatant (a),
and the cells (2) were then resuspended in 1 mL of NPG E-free medium for 20 min. After a
fluorescence measurement, supernatant (b) was isolated. The relative fluorescence emission
properties of both suspensions and supernatants were determined. According to Figure 3.1.7,
most of the fluorescence was found in the extracellular part of the first cell suspension (a) and a
significant fraction of the external medium of the second cell suspension (b). Since cell
suspension 2 began its incubation with only intracellular NPGA and perhaps some NPGE, the fact
that fluorescence made its way into the external medium demonstrated that NPG A underwent
efflux from the cells during the 20 min period.
We considered the possibility that during the initial isolation of cells via scraping some cells
were damaged resulting in progressive release of intracellular esterase activity and/or NPG into
the external medium. However, we repeated this experiment with CCRF-CEM cells, a cell line
that grows in suspension culture, and did not require scraping and obtained the same result
(Figure 3.1.8), ruling out the possibility that scraping had resulted in the appearance of NPG A in
the extracellular medium.
These findings are consistent with two hypotheses, either (i) NPGE is accumulated by cells and
undergoes internal esterase hydrolysis to NPGA which is then transported out of the cells or (ii)
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NPGE both moves into cells and is hydrolyzed on the extracellular surface of the cell. In the
absence of extracellular NPGE, the ester leaves the cell and undergoes ester hydrolysis. In
either case, the interaction of NPG with cells is considerably more complicated than anticipated
and results in most of the detectable sensor (NPGA) residing in the external medium.
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A.

B.

Figure 3.1.5 Reaction of LLC-PK1 cells with NPGE. (A) 107 LLC-PK1 cells suspended in 1 mL DPBS
were treated with 10 µM NPGE for 40 min at 25oC. Subsequently, 10 µM TPEN was added for
another 20 min. The reaction mixture, after 1 h, was centrifuged at 290 g and the extracellular
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medium separated from the cells. The cells were resuspended in 1 mL DPBS. Error bar
represents standard error for three measurements. (B) Background fluorescence of
extracellular medium (DPBS), and 107 LLC-PK1 cells suspended in DPBS at 25o C.

Figure 3.1.6 TPEN effect to the extracellular fluorescence: Reaction of TPEN with the
extracellular medium separated from the reaction of 10 7 LLC-PK1 cells with 10 µM NPGE for an
hour at 25o C. 10 µM TPEN incubated for 5 min.
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Figure 3.1.7 Efflux of NPGA from cells. 2.7  107 LLC-PK1 cells were reacted with 10 µM NPGE
for 40 min. The reaction mixture was centrifuged to separate the extracellular medium and
cells. The cells resuspended in 1 mL DPBS were incubated for another 20 min and then
centrifuged again to separate the extracellular medium and cells, which were then resuspended
in 1 mL DPBS.
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Figure 3.1.8 Reaction of CCRF-CEM cells and NPGE: (A) Reaction of 2 x 107 CCRF-CEM cells
suspended in DPBS at 25o C and 10 µM NPGE for about 40 min followed by the addition of 10
µM TPEN for another 20 min (arrow). (B) After one hour, the final reaction mixture was
centrifuged to separate extracellular medium and cell pellet. Cell pellet was subsequently
resuspended in 1 mL DPBS.
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3.1.4 Location of NPGA among cell constituents.
To characterize the intracellular properties of NPGA, cells isolated after one hour incubation
with NPGE were lysed and the supernatant subjected to Sephadex G-75 chromatography.
Proteome and low molecular weight fractions were assayed for Zn 2+ and fluorescence. Zn2+ was
associated with the high molecular weight proteome fractions, whereas fluorescent NPGA
emerged from the column without bound Zn2+ well beyond the total volume of the column
indicative of a favorable interaction between the Sephadex beads and NPG A (Figure 3.1.9).
Possibly, the chromatographic separation altered the original supernatant distribution. To
investigate this possibility, proteome and low molecular weight species were separated using
the Centricon filtration system and a 3 kDa cut-off filter. The majority of NPGA (about 85% of
total fluorescence intensity) was retained by the filter during centrifugation along with the
proteome (Figure 3.1.10). Thus, NPGA was weakly associated with protein in the supernatant
but was dissociated from the proteome during Sephadex chromatography.

3.1.5 Reaction of NPGE and NPGA with isolated proteome.
In order to gain a more detailed understanding of the reaction of NPG with cells, an analogous
set of experiments was conducted using isolated supernatant or proteome in place of whole
cells. NPGE was slowly hydrolyzed to NPGA by supernatant or proteome, indicative of the
presence of proteomic esterases that catalyze this conversion (Figure 3.1.11). As in cells, much
of the NPGA (84% of total fluorescence intensity) that was generated became associated with
the proteome as shown by centrifugal filtration. The addition of TPEN failed to quench the
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proteome-associated fluorescence (Figure 3.1.12), consistent with the conclusion that NPGA-Znproteins did not form during the enhancement of fluorescence.
NPGE  NPGA
Proteome + NPGA  ProteomeNPGA

Figure 3.1.9 Interaction of NPGA with Sephadex beads: Proteome (10 µM Zn2+) in 20 mM Tris
(pH 7.4) was reacted with 10 µM NPGA for 15 min at 25o C followed by Sephadex G-75 filtration
of the final reaction mixture. The eluted fractions were analyzed for both fluorescence and zinc.
Arrow shows total volume of the column.
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Figure 3.1.10 Centricon filtration of the reaction mixture of proteome and NPG A: 2.5  108 LLCPK1 cells suspended in DPBS were reacted with 10 µM NPGE for an hour in the dark. The cells
were then washed three times to remove the extracellular NPG and resuspended in MilliQ
water. Following sonication and centrifugation, the cell lysate was filtered using the Centricon
filtration system and a 3kDa cut-off filter to separate high molecular weight (retentate) and low
molecular weight (flow through) components.
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Figure 3.1.11 Reaction of proteome with NPGE. 4.2 mg/mL proteome in 20 mM Tris pH 7.4
containing 7 µM Zn2+ was incubated with 10 µM NPGE at ambient temperature (ca. 23o C) for 90
min. Fluorescence spectra were read every 15 min. The inset shows the progress of reaction
with time.
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Figure 3.1.12 Centricon filtration of the reaction mixture of proteome and NPG E. 4.2 mg/mL
proteome in 20 mM Tris pH 7.4 containing 7 µM Zn2+ was incubated with 10 µM NPGE at
ambient temperature (ca. 23o C) for 90 min. The final reaction mixture was separated by
Centricon filtration using 3K cut-off filter into the high molecular weight retentate and the low
molecular weight filtrate. 10 µM TPEN was added for 5 min to both retentate and flow through
fractions.
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3.1.6 Reactions of NPG with model Zn-proteins (alcohol dehydrogenase, carbonic anhydrase).
The cellular and proteomic experiments with NPG indicate that the sensor does not successfully
compete for native, proteomic Zn2+. But they do not exclude the possibility that NPG may form
ternary adducts with Zn-proteins that are insensitive to the presence of TPEN. To address this
issue, NPGE was reacted with two model Zn-proteins, alcohol dehydrogenase and carbonic
anhydrase, that are known to form TPEN-sensitive ternary adducts with the Zn2+ sensors, TSQ
and/or Zinquin (ZQ).50, 65 Upon incubation of NPGE with Zn-ADH, the fluorescence gradually
increased with time (Figure 3.1.13 A). However, TPEN was unable to quench the fluorescence.
Therefore, the fluorescence increase was indicative of the capacity of ADH to act upon NPGE as
an esterase not the ability of NPG to associate with one of ADH’s bound Zn 2+ ions. ZQ removes
1 Zn2+ from this protein as Zn(ZQ)2 and binds to the other to form a fluorescent adduct. 50 Both
are quenched by TPEN as it acquires Zn2+ from Zn(ZQ)2 and displaces ZQ from ZQ-Zn-ADH to
form TPEN-Zn-ADH.50 Together with this information, the current result strongly implies that
NPG neither binds to nor extracts Zn2+ from this protein. Similar results were obtained with ZnCA; the protein has NPGE esterase activity but is otherwise unreactive with NPG (Figure 3.1.14
A). Nevertheless, the majority of NPGA did associate with Zn2-ADH and Zn-CA according to
Centricon filtration analysis (Figure 3.1.13 B and 3.1.14 B).
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A.

B.

Figure 3.1.13 Reaction of alcohol dehydrogenase (ADH) with NPGE. (A) 2 µM alcohol
dehydrogenase was incubated with 10 µM NPGE at ambient temperature (ca. 23o C) for 90 min.
(B) Separation of the final reaction mixture by Centricon filtration using 3K cut-off filter.
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A.

B.

Figure 3.1.14 Reaction of carbonic anhydrase (CA) with NPGE. (A) 10 µM carbonic anhydrase
was incubated with 10 µM NPGE at ambient temperature (ca. 23o C) for 90 min. (B) Separation
of the final reaction mixture by Centricon filtration using 3K cut-off filter.
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3.1.7 Stability of Zn-NPGA with proteome.
It was evident that NPGA cannot compete with native, protein bound Zn2+ to form Zn-NPGA. We
then inquired whether it can compete for adventitiously bound Zn 2+ that might be produced
under certain physiological or pathological conditions. Initially, 10 µM Zn-NPGA was titrated
with proteome to test whether this species exhibits stability in the presence of protein
competitors for Zn2+. Figure 3.1.15 shows that addition of proteome up to about 50 µg
protein/mL (0-170 nM Zn2+ bound as Zn-protein) reduced the starting fluorescence intensity of
Zn-NPGA to that of an equivalent concentration of NPGA. Thus, NPGA does not compete
favorably with proteome for Zn2+.
Zn-NPGA + Proteome  Proteome Zn + NPGA
The capability of NPGA to compete with proteome for Zn2+ was probed another way: 4.2
mg/mL proteome containing 7 µM Zn-proteins was mixed with 10 M NPGA initially in 20 mM
Tris (pH 7.4) and then titrated with Zn2+ (Figure 3.1.16). NPGA fluorescence did not increase
until Zn2+ reached 30-35 μM or about 5x the total proteomic concentration of Zn 2+. At higher
concentrations of Zn2+, fluorescence emission at 535 nm increased; but even at 100 μM Zn 2+,
stoichiometric Zn-NPGA had not been generated, showing that proteomic sites continued to
partially sequester Zn2+ even at these large concentrations. Both experiments demonstrated
that under the described conditions, NPGA has little, if any, capacity to compete with native
proteome for Zn2+ that might be liberated from cellular binding sites during physiological or
pathological processes.
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Figure 3.1.15 Stability of Zn-NPGA in the presence of proteome. 10 µM Zn-NPGA complex was
titrated with the increasing concentration of proteome isolated from LLC-PK1 cells. Following
each addition of proteome, the fluorescence spectrum was recorded. The maximum
fluorescence intensity was plotted against the total concentration of proteome. The dilution of
the sample by 100 µg/mL proteome was only 2% and was ignored. The red square indicates the
baseline fluorescence of 10 µM NPGA.
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Figure 3.1.16 Titration of proteome with ZnCl2 in the presence of NPGA. 4.2 mg/mL proteome
(7 µM Zn2+ content) isolated from LLC-PK1 cells was titrated with ZnCl2 in the presence of 10 µM
NPGA. The reaction was performed in 20 mM Tris buffer at pH 7.4. Following each addition of
ZnCl2, the fluorescence spectrum was recorded, and the maximum fluorescence intensity was
plotted against the total concentration of the added ZnCl2. Control: 10 µM NPGA in 20 mM Tris
buffer at pH 7.4 was titrated with ZnCl2.
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We considered the possibility that proteins with substantial zinc buffering capacity might be
distributed among some organelles and not able to interfere with NPGA’s ability to image free
or loosely bound Zn2+ in other compartments. To investigate this possibility, 1.7 mg/mL of
cytosolic proteome (ca. 2.8 µM Zn2+), isolated by gentle homogenization of cells followed by
centrifugation at 100,000 x g, was mixed with 10 M NPGA and subsequently titrated with Zn2+
(Figure 3.1.17). A detectable increase of fluorescence was not observed until the added Zn 2+
reached about 10 M. Beyond that, NPGA partially competed with cytosolic proteome for
additional Zn2+. This result was in qualitative agreement with the findings with whole proteome
in the previous experiment and indicated that a subset of proteins within the cytosolic
proteome possesses substantially higher affinity for free or loosely bound Zn 2+ than does NPGA.
Similar results were obtained with membrane/nuclear and mitochondrial proteomes (Figure
3.1.17). All of the compartments displayed substantial Zn2+ buffering capacity.

3.1.8 Stability of Zn-NPGA with Glutathione.
The stability of Zn-NPGA was also studied in the presence of glutathione (GSH). GSH exists in
the cells in mM concentration and displays modest affinity for Zn 2+ (104.2. pH 7.2, 25o C).81 As
little as 30 M of GSH decreased the fluorescence intensity of 10 M Zn-NPGA by almost 80%
(Figure 3.1.18). The competition of glutathione for Zn 2+ with NPGA was also confirmed by the
titration of NPGA with Zn2+ in the presence of glutathione (Figure 3.1.19).
Zn-NPGA + Glutathione  Glutathione - Zn + NPGA
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Figure 3.1.17 Stability of Zn-NPGA with sub-cellular proteome. 1.7 mg/mL cytosolic proteome,
1.6 mg/mL mitochondrial proteome and 1.6 mg/mL nuclear proteome were titrated with ZnCl2
in the presence of 10 µM NPGA. Initially, subcellular proteome was incubated with NPGA for 15
min. The incubation period of NPGA with the subcellular fractions after each addition of Zn2+
was 5 min. The inset highlights the initial buffering region.
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Figure 3.1.18 Stability of Zn-NPGA in the presence of glutathione (GSH). 10 µM Zn-NPGA
complex in 20 mM Tris buffer at pH 7.4 was titrated with the increasing concentration of
glutathione (GSH). The incubation period after each addition was 5 min. Following each
addition, the fluorescence spectrum was recorded, and the maximum fluorescence intensity
was plotted against the glutathione concentration. The dilution of the sample by 40 µM GSH
was 2%. The red circle indicates the baseline fluorescence of 10 µM NPG A.
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Figure 3.1.19 Titration of NPGA with ZnCl2 in the presence of glutathione (GSH). 10 µM NPGA in
20 mM Tris buffer at pH 7.4 was titrated with ZnCl2 in the absence or presence of various
concentrations of glutathione. Following each addition of ZnCl2, the fluorescence spectrum was
recorded, and the maximum fluorescence intensity was plotted against the total concentration
of added ZnCl2. Initially, NPGA was mixed with GSH and for 5 min after each addition of Zn2+.
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3.1.7 Reaction of NPG and Zn-NPG with bovine serum albumin (BSA)
As albumin has a potential zinc binding site,82 10 µM Zn-NPGA was reacted with bovine serum
albumin (BSA) to test its stability in the presence of BSA. As a control, 10 µM NPG A was reacted
with 10 µM BSA. Figure 3.1.20 A shows that in control reaction, fluorescence increased by two
fold and the emission maximum of NPGA shifted significantly from 532 nm to 538 nm
suggesting the non-specific interaction of NPGA with BSA. BSA also reacted with Zn-NPGA with
an enhancement of fluorescence and wavelength shift from 532 nm to 538 nm indicative of
either specific interaction of Zn-NPGA with BSA (BSA-Zn-NPGA) through its zinc binding site or
non-specific interaction (BSA-NPGA-Zn). Regardless of the mode of interaction, this finding
further complicates the use of NPG as a cellular sensor, since it may undergo non-specific
interaction with cellular components. Following Centricon filtration of the final reaction mixture
using 3K cut-off filter, all the fluorescence was found in the retentate, which confirmed the
interaction of NPGA with BSA (Figure 3.1.20 B). To extend the understanding of the reaction
between Zn-NPGA and BSA, 10 µM Zn-NPGA was titrated with the increasing concentration of
BSA (Figure 3.1.21). Interestingly, fluorescence of Zn-NPGA initially decreased until a minimum
was reached and increased again at higher concentrations of BSA. In addition, the emission
maximum changed from Zn-NPG’s 532 nm to final 538 nm. This suggested that at lower
concentration of BSA, Zn2+ was extracted from Zn-NPGA by BSA, hence the reduction of
fluorescence was observed. However, at higher concentration of BSA, NPG binds BSA with an
enhancement of fluorescence and a wavelength shift.
Zn-NPG + BSA  Zn-BSA + NPG (at lower concentration of BSA)
BSA + NPG  BSA-NPG (at higher concentration of BSA)
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A.

B.

Figure 3.1.20 Reaction of NPGA and Zn-NPGA with bovine serum albumin (BSA). (A) 10 µM
NPG or Zn-NPG in 20 mM Tris buffer at pH 7.4 was reacted with 10 µM BSA for 15 min. (B)
Centricon filtration of the final reaction mixtures using 3K cut-off filter.
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A.

B.

Figure 3.1.21 Titration of Zn-NPGA with BSA: (A) 10 µM Zn-NPGA in 20 mM Tris (pH 7.4) was
titrated with the increasing concentration of BSA. (B) Change of maximum fluorescence
intensity and emission maximum with increasing concentration of BSA.
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3.1.9 Response of intracellular NPGA to added Zn2+.
The stability of Zn-NPGA within the cellular environment was also investigated. To do so, 1.5 x
107 LLC-PK1 cells were reacted with 10 µM NPGE for 30 min followed by washing to remove any
remaining extracellular medium. The cells resuspended in DPBS were subsequently treated for
20 min with a pre-incubated mixture of 10 µM ZnCl2 and 2 µM pyrithione, which served as an
ionophore to conduct Zn2+ into cells. During this time the internal concentration of Zn2+
increased from 1.8 nmoles/107 cells to 2.6 nmoles/107 cells, representing 15% of the added
Zn2+. An increase of fluorescence (173% of control) was observed after the addition of Znpyrithione (Figure 3.1.22). However, 10 µM EDTA rapidly reversed the fluorescence to 104% of
control suggesting that the elevation in fluorescence was mostly due to the binding of
extracellular Zn2+ to NPGA that had diffused out of the cells. The inability of 10 µM TPEN to
quench the remaining fluorescence ruled out the possibility that the residual 4% increase in
fluorescence originated from binding of added Zn2+ to intracellular NPGA. Instead, it probably
arose from the continuing hydrolysis of intracellular non-fluorescent NPGE to fluorescent NPGA.
Thus, although the intracellular Zn2+ concentration had increased almost 50%, no Zn-NPGA was
observed in the cells. Therefore, the results indicated that the intracellular NPG A did not
compete for adventitious Zn2+ within the cellular environment.
Zn out  Zn in
Zn in + Proteome + NPGA,in  ProteomeZnin + NPGA,in
NPGA,in  NPGA,out
NPGA,out + Zn-pyrout  Zn-NPGA,out + pyrout
Zn-NPGA,out + EDTA  Zn-EDTA + NPGA,out
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Figure 3.1.22 Reaction of NPGE incubated LLC-PK1 cells with Zn-pyrithione. 1.5x107 cells were
treated with 10 µM NPGE for 30 min, washed twice and resuspended in DPBS (control). A preincubated mixture of 10 µM ZnCl2 and 2 µM pyrithione was then added for 20 min. Pyr.
indicates pyrithione. Subsequently, 10 µM EDTA was introduced for 10 min followed by 10 µM
TPEN for another 10 min. Error bar represents standard error for three measurements.
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3.1.10 Reaction of proteome with thiol reactive agents NO and NEM in the presence of NPG A
To further examine if NPGA can image Zn2+ released from Zn-proteins, 3.6 mg/mL proteome
containing 12 M Zn-proteins was reacted with 200 M of the nitric oxide donor, diethylamine
NONOate (DEA-NO) in the presence of 10 µM NPGA. The NO produced from the breakdown of
DEA-NO can react with sulfhydryl groups in the Zn binding sites of the Zn-proteins resulting in
the release of Zn2+.27 A 17% increase of fluorescence upon addition of DEA-NO was observed,
which initially pointed to the release of Zn 2+ and the subsequent formation of Zn-NPGA (Figure
3.1.23). However, the observation that TPEN did not reduce the fluorescence undermined this
possibility. As a control, NPGA was reacted with DEA-NO to see if the sensor, itself, underwent
reaction with DEA-NO. A 50% increase of fluorescence was observed upon its reaction with
DEA-NO for 2 hours (Figure 3.1.23). Apparently, NPGA directly reacts with NO released from
DEA-NO, resulting in an enhancement of fluorescence.
NPGA’s weak ability to image adventitious Zn2+ released from the Zn-proteome was further
verified with the use of another thiol binding reagent, N-ethylmaleimide (NEM). 5.14 mg/mL
proteome containing 17 M Zn-proteins was reacted with NEM. A total of 500 M NEM
reduced the proteomic thiol concentration by almost 64% (from 352 µM to 125 µM) and caused
about a 12% increase of fluorescence of 10 µM NPGA, maximally equivalent to the formation of
about 1 M Zn-NPGA (Figure 3.1.24). The addition of 30 µM TPEN for 30 min reduced the
fluorescence to 109% of control. Thus, no more than 0.3 µM Zn-NPGA had actually formed. In
contrast, substituting 20 µM Zinquin for NPGA, the higher affinity zinc sensor displayed a 47%
increase of fluorescence after addition of only 100 µM NEM to the proteome. In the process,
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25% of the proteomic zinc (4.2 µM) was labilized by NEM, much of it becoming bound to
Zinquin.83

Figure 3.1.23 Reaction of proteome with diethylamine NONOate (DEA-NO) in the presence of
NPGA. Proteome (10 µM Zn2+) isolated from LLC-PK1 cells was reacted with with 200 µM DEANO for 90 min in the presence of 10 µM NPGA followed by the treatment with 10 µM TPEN for
30 min. The fluorescence was recorded continuously. 10 µM NPGA in Tris was reacted with 200
µM DEA-NO for 2 hours as a control. Prot. indicates proteome.
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Figure 3.1.24 Reaction of proteome with N-ethylmaleimide (NEM) in the presence of NPGA.
Proteome (17 µM Zn2+) was reacted with 500 µM NEM in the presence of 10 µM NPGA for 30
min. Subsequently, 30 µM TPEN was added for another 30 min. Error bar represents standard
error for three measurements.
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3.2 Chemical Biology of Zinpyr-1 (ZP1)
Having found that Newport Green, a low affinity zinc senor, is unable to form intracellular ZnNPG complex by outcompeting proteome’s non-specific Zn2+ binding sites, for comparison, the
chemical-biological properties of a relatively higher affinity sensor, Zinpyr-1 (ZP1), were studied.
ZP1 has a dichlorofluorescein as the fluorophore and two appended di-2-picolylamine (DPA)
moieties as Zn2+ binding ligands (Figure 1.2). Of these two binding sites, one is of higher affinity
(Kd 0.7 nM) than the second one (Kd 85 µM).1 Various articles have reported the intracellular
imaging of Zn2+ by ZP1.84-89 However, due to its high affinity Zn2+ binding site, it may undergo
other possible reactions. For example, ZP1 may directly react with the native Zn-proteins and
thus perturb the equilibrium between the bound and the free Zn 2+ (reaction 3.2.1).
 Zn-protein + ZP1 ⇌  apo-protein + ZP1(Zn)2

(3.2.1)

Moreover, like Zinquin (ZQ) which also has nanomolar stability constant, ZP1 can form ternary
adduct with specific Zn-proteins and generate ZP1-Zn-Protein ternary adduct (reaction 3.2.2).
 Zn-protein + ZP1 ⇌  ZP1-Zn-Protein

(3.2.2)

From Newport Green study, we have seen that proteome possesses a zinc buffering capacity.
So, ZP1 can also interact with Zn2+ adventitiously bound to various non-specific proteomic sites
(reaction 3.2.3).
Proteome + Zn2+ + ZP1 ⇌ ProteomeZn-ZP1

(3.2.3)

This study investigated all these possible reactions of ZP1 both in vitro and in vivo.
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3.2.1 Reaction of ZP1 with ZnCl2
To investigate the spectral properties of ZP1, 10 µM ZP1 in 20 mM Tris (pH 7.4) was titrated
with the increasing concentration of ZnCl2 (Figure 3.2.1 A). When excited at 515 nm, the
solution of ZP1 (pink in color) in Tris shows very little fluorescence centered at 535 nm. As ZnCl 2
is added, it expectedly first binds the higher affinity site of ZP1 with a very small enhancement
of fluorescence and the emission maximum stays at 535 nm as of ZP1 solution itself. Once the
higher affinity Zn2+ binding is occupied and half-saturated ZP1-Zn forms, added Zn2+ starts
binding to the lower affinity site with much higher increase of fluorescence and a wavelength
shift from 535 nm to 525 nm to generate the fully saturated ZP1(Zn)2 complex. As fully
saturated ZP1(Zn)2 forms, the color of the solution changes from pink to green.
ZP1 + Zn2+  ZP1-Zn (535 nm, pink, weakly fluorescent)
ZP1-Zn + Zn2+  ZP1(Zn)2 (525 nm, green, strongly fluorescent)
The first Zn2+ binding to ZP1 with weak fluorescence and the second with strong fluorescence
gives the titration curve a sigmoidal shape (Figure 3.2.1 B). Since the binding of Zn2+ to the
stronger site results in very weak fluorescence, the use of ZP1 as a cellular sensor becomes
complicated.
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A.

B.

Figure 3.2.1 Titration of ZP1 with Zn2+: (A) 10 µM ZP1 in 20 mM Tris (pH 7.4) was titrated with
increasing concentration of ZnCl2. (B) Change of fluorescence of ZP1 as it binds Zn2+.
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3.2.2 Reaction of LLC-PK1 cells with ZP1
As 107 LLC-PK1 cells were incubated with 10 µM ZP1 for 15 min, very small fluorescence
centered at 535 nm was observed that did not change over time (Figure 3.2.2 A). Since ZP1-Zn
fluoresces with an emission maximum of 525 nm, the max of 535 nm in this reaction indicates
either no reaction of ZP1 with the native Zn-proteome, as ZP1 solution itself shows very weak
fluorescence at 535 nm, or some reaction other than the formation of ZP1-Zn. However, 30 µM
TPEN, a very strong, intracellular zinc chelator, could not reverse the fluorescence that resulted
from the reaction of LLC-PK1 cells and ZP1 (Figure 3.2.2 B), suggesting no involvement of native
Zn2+ in the observed fluorescence. Nevertheless, it is difficult to draw any conclusion from this
experiment, as we have seen from previous experiment (titration of ZP1 with Zn 2+) that the
intital zinc binding gives very weak fluorescence. Therefore, even if there may be some
reactions of ZP1 with the native configuration of Zn2+, it’s unlikely to be observed and any effect
of TPEN is also not expected. To test whether the observed fluorescence has originated due to
the binding of extracellular Zn2+, 30 µM EDTA (ethylenediaminetetraacetic acid), a cell
impermeable Zn2+ chelator, was introduced to the reaction of LLC-PK1 cells and ZP1. Like TPEN,
EDTA couldn’t affect the fluorescence either ruling out the possibility of the involvement of any
extracellular Zn2+ (Figure 3.2.2 B).
To further investigate the source of this fluorescence, 2 x 108 LLC-PK1 cells in DPBS were
incubated with 10 µM ZP1 for 15 min. Subsequently, the cell suspension was centrifuged and
washed with fresh DPBS to remove any extracellular ZP1. The washed cell suspension
resuspended in 1 mL MilliQ water was sonicated, centrifuged and the resultant cell lysate was
fractionated using Sephadex G-75 gel filtration column. Following the elution of the fractions
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with degassed 20 mM Tris (pH 7.4), all the collected fractions were analyzed for both
fluorescence and zinc content. As figure 3.2.3 shows that the majority of the fluorescence
resided in the high molecular weight fractions and nicely aligned with Zn 2+ concentration in
those fractions. The fluorescence in the high molecular weight fractions may suggest the
formation of ternary adduct, ZP1-Zn-Protein from the reaction between Zn-Protein and ZP1.
Zn-Protein + ZP1  ZP1-Zn-Protein
Moreover, a small band of fluorescence in low molecular weight region also appeared, although
no zinc was associated with this fluorescence indicating the low molecular weight fluorescence
resulted from unbound ZP1.
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A.

B.

Figure 3.2.2 Reaction of LLC-PK1 cells with ZP1. (A) 107 LLC-PK1 cells in DPBS were reacted with
10 µM ZP1 for 15 min. (B) Effect of 30 µM TPEN and 30 µM EDTA on the fluorescence resulted
from the reaction of LLC-PK1 cells and 10 µM ZP1.
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Figure 3.2.3 Locating fluorescent species in the reaction of LLC-PK1 cells and ZP1. 2 x 108 LLCPK1 cells suspended in DPBS were incubated with 10 µM ZP1 for 15 min. The cell suspension
was then centrifuged and resuspended in fresh DPBS, and this was repeated two more times.
Finally the cells were resuspended in MilliQ water, sonicated, centrifuged, and the resultant cell
lysate was loaded onto a Sephadex G-75 gel filtration column. The fractions eluted with
degassed 20 mM Tris buffer (pH 7.4) were analyzed for fluorescence and zinc content.
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3.2.3 Reaction of ZP1 with isolated proteome
Isolated proteome (9 µM Zn2+) from LLC-PK1 cells was reacted with 10 µM ZP1. A significant
increase of fluorescence compared to blank (ZP1 solution in Tris buffer) was observed and the
emission maximum was found to be about 540 nm (Figure 3.2.4). 20 µM TPEN reduced the
enhancement by about 44% (Figure 3.2.4B) indicating the participation of Zn2+ in the increment
of fluorescence and the formation of ZP1-Zn-Proteome ternary adduct.
To acquire a better insight into this reaction, the final reaction mixture following the incubation
of isolated proteome (10 µM Zn2+) with 10 µM ZP1 for 15 min was fractionated using a
Sephadex G-75 gel filtration column. When the fractions eluted with 20 mM Tris (pH 7.4) were
analyzed for fluorescence, most of the fluorescence was found in the high molecular weight
region (Figure 3.2.5 A). This again suggested that ZP1 formed ternary adduct, ZP1-Zn-Proteome,
with Zn-Proteome. A small low molecular weight pool of fluorescence also appeared, that might
possibly be attributed to the unbound ZP1. As the high molecular weight fractions were reacted
with 10 µM TPEN, the integrated fluorescence intensity was brought down by about 25%
considering that ZP1 itself shows some fluorescence (Figure 3.2.5 B). TPEN effect further
confirms the formation of ZP1-Zn-Proteome ternary adduct, in which TPEN may either removes
Zn2+ from the adduct to form Zn-TPEN complex or replaces ZP1 to form TPEN-Zn-proteome.
ZP1-Zn-Proteome + TPEN  Zn-TPEN + ZP1 + apo-Proteome
ZP1-Zn-Proteome + TPEN  TPEN-Zn-Proteome + ZP1
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A.

B.

Figure 3.2.4 Reaction of ZP1 with isolated proteome. (A) Isolated proteome containing 9 µM
Zn2+ in 20 mM Tris buffer (pH 7.4) was reacted with 10 µM ZP1. (B) Effect of 20 µM TPEN on the
fluorescence.
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A.

B.

Figure 3.2.5 Sephadex G-75 gel filtration of the reaction mixture of isolated proteome (10 µM
Zn2+) and ZP1. (A) Isolated proteome (10 µM Zn2+) in 20 mM Tris buffer (pH 7.4) was reacted
with 10 µM ZP1. The final reaction mixture was then passed through a Sephadex G-75 gel
filtration column and was eluted with 20 mM Tris (pH 7.4) buffer. The eluted fractions were
analyzed for fluorescence. (B) Effect of 10 µM TPEN on the integrated fluorescence intensity of
high molecular weight (HMW) fractions.
70

3.2.4 Titration of proteome with Zn2+ in the presence of ZP1
As fluorescent sensors are used to image Zn2+ liberated from various cellular zinc binding sites
or Zn2+ released from different cellular zinc stores, e.g. endoplasmic reticulum, ZP1 was probed
to determine if it forms ternary adduct, Proteome-Zn-ZP1, with proteome and added Zn2+. In
doing so, isolated proteome containing 9 µM Zn2+ was incubated with 10 µM ZP1 for 15 min.
The resultant fluorescence intensity with an emission maximum of 540 nm suggested the
formation of ternary adduct, ZP1-Zn-Protein, from the reaction of ZP1 and native Zn-Protein.
ZP1 + Zn-Protein  ZP-Zn-Protein
Following the incubation of proteome and ZP1 for 15 min, the final reaction mixture was
titrated with the increasing concentration of Zn2+ (Figure 3.2.6 A and B). As Zn2+ was added,
fluorescence intensity immediately increased. This immediate change of fluorescence indicated
that this was not just simple titration of ZP1 with Zn2+, in which the initial strong binding gives
little fluorescence. Thus, the fluorescence increase in this titration is not due to the formation
of ZP1-Zn complex. Moreover, as the fluorescence intensity further increased with the addition
of more zinc, the emission maximum stayed unchanged at 535-540 nm. This differs from the
titration of ZP1 with Zn2+, where initially the emission maximum is 540 nm at low concentration
of Zn2+ and low fluorescence intensity, but shifts to 525 nm as the concentration of Zn 2+
increases with higher fluorescence intensity. All these differences from the titration of ZP1 and
Zn2+ suggested the formation of ProteomeZn-ZP1 ternary adduct, where the added Zn2+ binds
various adventitious zinc binding sites of proteome which in turn binds ZP1.
Proteome + ZP1 + Zn2+  Proteome.Zn-ZP1
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To confirm the notion of ProteomeZn-ZP1 ternary adduction generation, the final reaction
mixture following the titration of proteome with Zn 2+ in the presence of ZP1 was fractionated
using a Sephadex G-75 gel filtration column. As the fractions eluted with 20 mM Tris buffer (pH
7.4) were analyzed for both fluorescence and zinc content, most of the fluorescence was found
associated with the high molecular weight fractions (Figure 3.2.6 C). The emission maximum of
the fluorescence spectrum in these fractions was found to be 535 nm. Moreover, the
fluorescence intensities in high molecular weight fractions were very consistent with the zinc
concentrations in those fractions (Figure 3.2.7 A). The residence of the majority of the
fluorescence in the high molecular weight fractions further points to the formation of
ProteomeZn-ZP1 ternary adduct. However, a small low molecular weight fluorescence pool
also emerged. The absence of measurable zinc in those low molecular weight fractions
indicated that the unbound ZP1 might be attributed to this small pool of fluorescence. The
effect of 10 µM TPEN on the fluorescence intensities of the high molecular weight fractions
further validates the claim of the generation of ternary adduct, ProteomeZn-ZP1 in this
reaction. TPEN quenched the integrated fluorescence intensity of the high molecular weight
proteomic fractions almost by 50% (Figure 3.2.7 B).
ProteomeZn-ZP1 + TPEN  Proteome + Zn-TPEN + ZP1
ProteomeZn-ZP1 + TPEN  ProteomeZn-TPEN + ZP1
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A.

B.

Figure 3.2.6 Titration of proteome with Zn2+ in the presence of ZP1. (A) Proteome containing 9
µM Zn2+ was reacted with the increasing concentration of Zn2+. (B) Change of fluorescence with
the increasing concentration of Zn2+.
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A.

B.

Figure 3.2.7 Sephadex gel filtration of the proteome titrated with ZnCl 2 in the presence of ZP1.
(A) Proteome (9 µM Zn2+) was reacted with the increasing concentration of Zn 2+.The final
reaction mixture was fractionated using a Sephadex G-75 gel filtration column and the fractions
eluted with 20 mM Tris (pH 7.4) were analyzed for both fluorescence and zinc content. (B)
Effect of 10 µM TPEN on the integrated fluorescence intensity of high molecular weight
fractions.
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3.2.5 Reaction of proteome with Zn-ZP1
The formation of ternary adduct ProteomeZn-ZP1 following the reaction of isolated proteome
with ZP1 and added Zn2+ was investigated another way. Isolated proteome containing 9 µM Zn 2+
was reacted with pre-mixed ZP1(Zn)2. As 20 µM ZP1(Zn)2 (emission maximum of 525 nm) was
added to proteome, the emission maximum shifted to 540 nm indicating the production of
ProteomeZn-ZP1 ternary adduct species (Figure 3.2.8 A).
Proteome + ZP(Zn)2  ProteomeZn-ZP1
To confirm the generation of ProteomeZn-ZP1 ternary adduction species, the final reaction
mixture was fractionated using a Sephadex G-75 gel filtration column. As the fractions eluted
with 20 mM Tris buffer (pH 7.4) were analyzed for both fluorescence and zinc content, most of
the fluorescence (63%) was found associated with the high molecular weight fractions (Figure
3.2.8 B). The emission maximum of the fluorescence spectrum in these fractions was found to
be 535 nm. Moreover, the fluorescence intensities in high molecular weight fractions were very
consistent with the zinc concentrations in those fractions. The residence of the majority of the
fluorescence in the high molecular weight fractions further points to the formation of
ProteomeZn-ZP1 ternary adduct. However, a small low molecular weight fluorescence pool
also emerged. The absence of measurable zinc in those low molecular weight fractions
indicated that the unbound ZP1 might generate this small pool of fluorescence. The effect of 10
µM TPEN on the fluorescence intensities of the high molecular weight fractions further
validated the claim of the generation of ternary adduct, ProteomeZn-ZP1 in this reaction.
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TPEN quenched the integrated fluorescence intensity of the high molecular weight proteomic
fractions almost by 82% (Figure 3.2.8 C).
A.

B.
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C.

Figure 3.2.8 Reaction of proteome with ZP1(Zn)2. (A) Reaction of proteome (9 µM Zn2+) with 10
µM and 20 µM ZP1(Zn)2. (B) The final reaction mixture was loaded onto a Sephadex G-75 gel
filtration column and the fractions were eluted with 20 mM Tris buffer (pH 7.4). Both
fluorescence and zinc content were determined for each of the eluted fractions. (C) Effect of 20
µM TPEN on the integrated fluorescence intensity of the high molecular weight fractions.
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3.2.6 Reaction of ZP1 with TSQ-Zn-Proteome
As TSQ reacts with Zn-proteome and forms ternary adduct TSQ-Zn-Proteome, ZP1’s ability to
replace TSQ from this ternary adduct and, thus, to form new ternary adduct species ZP1-ZnProteome was probed. In doing so, isolated proteome containing 12 µM Zn 2+ was first reacted
with 20 µM TSQ for an hour. As expected, a gradual increase of fluorescence with an emission
maximum of 470 nm – signature of the generation of TSQ-Zn-Proteome ternary adduct species
– was observed. Afterwards, the reaction mixture was titrated with the increasing
concentration of ZP1, the fluorescence intensity at 470 nm rapidly quenched and at the same
time, a fluorescence peak at 535 nm, which gradually shifted to 540 nm at higher concentration
of ZP1, appeared (Figure 3.2.8 A). The loss of fluorescence intensity at 470 nm and the
emergence of fluorescence at 535-540 nm suggest the replacement of TSQ from the ternary
adduct TSQ-Zn-Proteome (470 nm) and as such the creation of the new ternary adduct ZP1-ZnProteome (540 nm).
Zn-Proteome + TSQ  TSQ-Zn-Proteome
TSQ-Zn-Proteome + ZP1  ZP1-Zn-Proteome + TSQ
We also considered the possibility that the reduction of fluorescence intensity at 470 nm
following the introduction of ZP1 might be attributed to the inner filter effect, i.e. ZP1 remains
unreactive with TSQ-Zn-Proteome and instead, absorbs the emitted light at 470 nm and thus
quenches the fluorescence. Despite the fact that the non-linear loss of fluorescence at 470 nm
with the increasing concentration of ZP1 ruled out the possibility of inner filter effect (Figure
3.2.9 B), for further confirmation we fractionated the final reaction mixture using a Sephadex
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G-75 gel filtration column and compared the fluorescence intensities of the high molecular
weight fractions with those of a control experiment, in which isolated proteome containing 12
µM Zn2+ was reacted with 20 µM TSQ followed by the fractionation of the final reaction
mixture. In the case of the ZP1 treated reaction, the fluorescence intensity at 470 nm of the
high molecular weight fractions was much lower (Figure 3.2.10 B) compared with that of the
control experiment (Figure 3.2.10 A). If the reduction of fluorescence at 470 nm were due to
the inner filter effect of ZP1, the fluorescence intensities of high molecular weight fractions
should have returned following gel filtration. In fact, the integrated fluorescence intensities at
470 nm of high molecular weight fractions turned out to be only 39% of those of the control
experiment (Figure 3.2.11 A). All these findings cancel the possibility that the inner filter effect
of ZP1 played any role in reducing the fluorescence of TSQ-Zn-Proteome ternary adduct at 470
nm. Furthermore, the quenching of the integrated fluorescence intensity of 540 nm of the high
molecular weight fractions by 40-50% by 20 µM TPEN further confirms the formation of a ZP1Zn-Proteome ternary adduct that replaces TSQ from TSQ-Zn-Proteome (Figure 3.2.11 B).
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A.

B.

Figure 3.2.9 Reaction of ZP1 and proteome incubated with TSQ. (A) Proteome (12 µM Zn2+)
was reacted with 20 µM TSQ for an hour. Following on, the reaction mixture was titrated with
ZP1. (B) Change of fluorescence at 470 nm, 540 nm, control 540 nm and ZP1 absorbance with
the increasing concentration of ZP1.
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A.

B.

Figure 3.2.10 Sephadex gel filtration of proteome reacted with TSQ and ZP1. (A) Control: The
final reaction mixture of proteome and 20 µM TSQ was fractionated using a Sephadex G-75 gel
filtration column and the high molecular weight fractions eluted with 20 mM Tris buffer (pH
7.4) were analyzed for fluorescence. (B) Fluorescence spectrum of the high molecular weight
fractions collected by fractionation of the final reaction mixture of proteome, TSQ and ZP1.
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C.

D.

Figure 3.2.11 Integrated fluorescence of high molecular weight (HMW) fractions and TPEN
effect. (A) Comparison of the integrated fluorescence intensities of the high molecular weight
fractions between control and ZP1 treated reactions. (B) The effect of 20 µM TPEN on the
integrated fluorescence intensity of the high molecular weight fractions of ZP1 treated reaction.
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3.2.7. Reaction of ZP1 with model zinc proteins, such as alcohol dehydrogenase
ZP1 formed ternary adduct ZP-Zn-Proteome with native Zn-Proteome and Proteom.Zn-ZP1 with
proteome and added Zn2+. Next we wanted to investigate if ZP1 forms ternary adduct with
different model Zn-proteins, such as alcohol dehydrogenase. Each alcohol dehydrogenase
monomer unit has one catalytic zinc and one structural zinc.90
As 10 µM ZP1 in 20 mM Tris (pH 7.4) was titrated with the increasing concentration of alcohol
dehydrogenase (ADH), a small but gradual enhancement of fluorescence was observed (Figure
3.2.12 A). The emission maximum of the fluorescence spectrum stayed at 536 nm. These
observations suggested the generation of ternary adduct ZP1-Zn-ADH between ZP1 and alcohol
dehydrogenase (Zn-ADH). However, even after the addition of alcohol dehydrogenase that
contained 60 µM Zn2+, the fluorescence intensity was still gradually increasing indicating weak
interaction between ZP1 and alcohol dehydrogenase. As the final reaction mixture was reacted
with 20 µM TPEN, the fluorescence intensity was almost completely reversed to the blank (ZP1
in Tris) (Figure 3.2.12 B). The TPEN effect further suggests the formation of ternary adduct
species, ZP1-Zn-ADH and its reaction with TPEN as follows:
ZP1 + Zn-ADH  ZP1-Zn-ADH
ZP1-Zn-ADH + TPEN  Zn-TPEN + ZP1 + ADH
ZP1-Zn-ADH + TPEN  TPEN-Zn-ADH + ZP1
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To further confirm the formation of ternary adduct ZP1-Zn-ADH, the final reaction mixture of 10
µM ZP1 and alcohol dehydrogenase containing 60 µM Zn 2+ was fractionated using a Sephadex
G-75 gel filtration column and the fractions were eluted with 20 mM Tris buffer (pH 7.4). As the
fractions were analyzed, the majority of the fluorescence was found in the low molecular
weight region (Figure 3.2.12 C). This might be due to the weak binding of ZP1 and Zn-ADH in
forming ZP1-Zn-ADH ternary adduct that was implied in the earlier experiment described by
Figure 3.2.9 A and its subsequent dissociation during gel filtration.
ZP1-Zn-ADH  ZP1 + Zn-ADH
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A.

B.
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C.

Figure 3.2.12 Reaction of ZP1 with alcohol dehydrogenase. (A) 10 µM ZP1 in 20 mM Tris (pH
7.4) was reacted with increasing concentration of alcohol dehydrogenase. (B) The effect of 20
µM TPEN on the reaction between 10 µM ZP1 and alcohol dehydrogenase containing 60 µM
Zn2+. (C) Fractionation of the final reaction mixture of 10 µM ZP1 and alcohol dehydrogenase
containing 60 µM Zn2+ and the measurement of fluorescence of the fractions.
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3.3 Reaction of Zn-proteome with Diethylamine NONOate (DEA-NO) in the
presence of Zinquin/TSQ/FluoZin-3
The in vitro titration of proteome with Zn2+ in the presence of Newport Green (NPG) or Zinpyr-1
(ZP1) – a model of intracellular reaction of the sensor with the mobile Zn 2+ in the presence of
proteomic zinc binding ligands – has displayed two different results with two sensor with
dissimilar stability constants. NPG, because of its low stability constant (10 -5 – 10-6 M), could not
compete with the proteome and form Zn-NPG (reaction 3.3.1), while the higher affinity sensor
ZP1 (0.7 nM) generated ProteomeZn-ZP1 ternary adduct (reaction 3.3.2). Neither could form
Zn-Sensor complex.
Proteome + Zn2+ + NPG ⇌ ProteomeZn + NPG

(3.3.1)

Proteome + Zn2+ + ZP1 ⇌ ProteomeZn-ZP1

(3.3.2)

These findings clearly show that the ability of the zinc senor to image intracellular mobile Zn 2+
depend on its relative binding affinity compared to that of the proteomic ligands. To rationalize
this finding in terms of an actual cellular process that triggers the release of Zn 2+, LLC-PK1 cells
were reacted with nitric oxide (NO), which reacts with the proteomic sulfhydryl groups that
coordinate Zn2+ in specific proteins and thus causes the liberation of Zn2+.86 The sensor’s ability
of imaging this mobile released Zn2+ was studied using three different fluorescent zinc sensors –
Zinquin (ZQ), TSQ and FluoZin-3.
Nitric oxide (NO) acts as a regulatory molecule, which induces the release of Zn2+ following its
reaction with sulfhydryl groups.91-94 However, the nitrosation of the sulfhydryl groups by nitric
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oxide is not straightforward. The following reactions describe the various ways the thiol groups
are nitrosated by reactive nitrogen oxide species.95
2 ·NO + O2  2 ·NO2
2 ·NO + 2 ·NO2  2 N2O3
N2O3 + RSH  RSNO + NO2- + H+

RSH + ·NO2  RS· + NO2- + H+
RS· + ·NO  RSNO

The sulfhydryl groups can be oxidized as well following the reaction with nitric oxide. 95
RS· + ·SR  RSSR
RS· + O2  RSOO·
RS· + RS-  RSSR·RSSR·- + O2  RSSR + O2·-

Previous studies have reported that the primary target of NO is Zn 7-metallothionein (Zn7-MT),
which binds 7 Zn2+ ions in two thiolate clusters.54, 56, 96-98 For example, Pitt et al. hypothesized
that nitric oxide exposed to or synthesized within lung endothelial cells reacts with thiolate
groups of Zn7-MT and releases Zn2+.54 The liberation of Zn2+ was supported from the
fluorescence enhancement of the sensors ZQ and FluoZin-3. However, other studies have found
that NO is not particularly reactive with Zn7-MT.15 Therefore, questions arise as to the source of
Zn2+ imaged by these sensors and the identity of the fluorescent species that causes the
enhancement of fluorescence. An alternative possible source of Zn2+ released following NO
exposure is proteomic Zn2+, which is then sensed by ZQ and FluoZin-3 in the above mentioned
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study. However, as ZQ and TSQ image Zn-proteins through the formation of ZQ/TSQ-Zn-Protein
ternary adduct, they may also generate ProteomeZn-ZQ/TSQ with Zn2+ adventitiously bound
to proteome upon release.
Zn-S-Proteome + NO ⇌ NO-S-Proteome + Zn2+
Proteome + Zn2+ + ZQ/TSQ ⇌ ProteomeZn-ZQ/TSQ
These present experiments were undertaken to better understand the underlying chemistry of
the reaction of proteome with nitric oxide (NO) monitored by the fluorescent zinc sensor
Zinquin, TSQ and FluoZin-3.
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3.3.1. Reactions of the LLC-PK1 cells with DEA-NO in the absence or presence of Zinquin (ZQ).
Pig kidney LLC-PK1 cells were used to investigate the impact of nitric oxide on the availability of
intracellular Zn2+ to react with fluorescent zinc sensors. DEA-NO, which releases NO with a half
time of about 20 min, served as the source of nitric oxide.86 Initially, 1x107 LLC-PK1 cells were
incubated with 20 µM Zinquin ethyl ester (ZQee) for 30 min. During this time the charge neutral
probe diffused into the cells and began to undergo ester hydrolysis. A fluorescence emission
spectrum centered at 470 nm was observed, indicative of the formation of a ternary adduct
species, ZQ-Zn-Proteome (Figure 3.3.1 A).50 Based on previous estimates, the amount of
protein-bound zinc participating in adduct formation represents about 10-15% of the total.50
The introduction of 500 µM DEA-NO to the cells for another 25 min reduced the sulfhydryl
concentration from 78 µM to 44 µM and caused a gradual increase of fluorescence at 470 nm,
along with a noticeable shoulder at 490 nm (Figure 3.3.1 A). Moreover, the fluorescence ratio
at 490 nm to 470 nm increased along the course of the reaction (Figure 3.3.1 B). Compared
with the reaction of cells with ZQee, a 25% increment in fluorescence intensity was observed
(Figure 3.3.1 C) – consistent with the study by Pitt et al.54 Subsequently, 10 µM TPEN, a cell
permeable, strong zinc chelator, reversed the fluorescence to 17% of the baseline of cell
background fluorescence (Figure 3.3.1 C), confirming that both enhancement of fluorescence
followed by the treatment of ZQee and then DEA-NO involved the participation of Zn2+.

90

A.

B.
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Figure 3.3.1 Reaction of LLC-PK1 cells with DEA-NO in the presence of Zinquin ethyl ester: (A)
Fluorescence spectra of the reaction between 107 LLC-PK1 cells and 20 µM Zinquin ethyl ester
(ZQee) for 30 min followed by the treatment with 500 µM DEA-NO for another 25 min. (B) The
change of fluorescence ratio at 490 nm to 470 nm with time. (C) Percent enhancement of
fluorescence upon addition of 500 µM DEA-NO and its reversal by 10 µM TPEN.
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The appearance of the shoulder at 490 nm suggested the mobilization of Zn 2+ by NO released
spontaneously from DEA-NO and, in turn, the production of the Zn(ZQ)2 complex (Reaction 1),
which fluoresces with an emission maximum of 490 nm.1-3 Another contributor to the
fluorescence increase at 470 nm might be Zn2+ mobilized from Zn-proteins that non-specifically
rebound to other adventitious binding sites. In turn, Zn●Proteome may bind ZQ to generate
Zn-ZQ●Proteome species that fluoresce at 470 nm.
Zn-S-Protein + NO + 2 ZQ ⇌ NO-S-Protein + Zn(ZQ)2

(1)

To investigate further the basis for the above observations, 1.25 x 10 8 LLC-PK1 cells were
incubated with 20 µM ZQee for 30 min at room temperature before the subsequent addition of
500 µM DEA-NO for another 40 min. The cells were then lysed, centrifuged and the resultant
supernatant separated by gel filtration using a Sephadex G-75 column. As the fractions were
analyzed for both fluorescence and zinc content, high molecular weight (HMW) and low
molecular weight (LMW) pools for both fluorescence and zinc were found for both control
(reaction of cells and ZQee) and DEA-NO treated (reaction of cells and ZQee followed by DEANO) cells (Figure 3.3.2A & B). In addition, proteome associated fluorescence increased by 16%
in DEA-NO treated cells compared to control. The low molecular weight fluorescence pool of
control reaction constituted 19% of the total fluorescence (high molecular weight and low
molecular weight), whereas that of DEA-NO treated reaction represented 32% (Figure 3.3.2C).
The spectra of low molecular weight fractions centered around 490 nm. Consistent with the
fluorescence data, the low molecular weight zinc content after DEA-NO treatment was
calculated to be 13% of the total zinc, whereas that of control reaction was only 5 % (Figure
3.3.2C).

The significant increase of both the low molecular weight zinc content and its
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accompanying fluorescence emission centered at 490 nm indicated the formation of Zn(ZQ)2
during the reaction of NO with cells. ZQ may have reacted with Zn 2+ associated with or released
from native Zn2+ binding sites that had been modified and weakened by nitric oxide.
Alternatively, Zn2+ at such sites may have shifted to non-specific sites of binding within the
proteome and reacted with ZQ to generate Zn(ZQ)2 (reactions 2 and 3):
Zn-NOS-Proteins + Proteome ⇋ NO-S-Proteins + Zn●Proteome
2 ZQ + Zn●Proteome ⇌ Zn(ZQ)2 + Proteome
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(2)
(3)

A.

B.
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C.

Figure 3.3.2 Sephadex G-75 filtration of LLC-PK1 cells incubated with 20 µM Zinquin ethyl ester
(ZQee) followed by 500 µM DEA-NO. (A) 108 LLC-PK1 cells were reacted with 500 µM DEA-NO
for 40 min following 20 µM ZQee for 30 min. The cells were lysed, centrifuged, and the
supernatant was separated using a Sephadex G-75 column. The fractions were analyzed for
both fluorescence and zinc. (B) Control: a parallel reaction was run at identical condition with
no DEA-NO added. (C) Comparison of the low molecular weight (LMW) fluorescence and zinc
content between control and DEA-NO exposed cells.
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3.3.2. Reaction of isolated proteome with DEA-NO in the presence of Zinquin acid (ZQacid).
To verify the interpretation of the reaction of NO and ZQ with LLC-PK1 cells, isolated proteome
(10 µM Zn2+) was first reacted with 20 µM ZQacid for 45 min at room temperature. As in whole
cells, a gradual increase of fluorescence with the emission maximum of 470 nm was observed,
indicative of the formation of ZQ-Zn-Protein ternary adduct. Subsequently, 500 µM DEA-NO
was added for an hour. When the final reaction mixture was separated using a Sephadex G-75
column, a noticeable low molecular weight pool of fluorescence and zinc – larger than that of
control – was seen (Figure 3.3.3 A & B). The LMW fluorescence pool (emission maximum of 490
nm) was measured to be 50% of total fluorescence, which is 40% greater than that of control
(30% of total fluorescence) and displayed an emission maximum at 490 nm (Figure 3.3.3C).
Consistently, the LMW zinc pool was found to three times greater than that of control
proteome (15% of total zinc content vs. 5%). The reduction of sulfhydryl content by 41% (from
212 µM to 126 µM) following the treatment with DEA-NO (Figure 3.3.3D) supported the
reaction between proteomic sulfhydryl groups and nitric oxide. As in whole cells, the low
molecular weight fluorescence and zinc pool in the reaction of isolated proteome indicated the
production of Zn(ZQ)2. Moreover, proteome fluorescence intensity increased by 19% of the
control suggesting the generation of new ternary adduct sites resulted from the labilization of
Zn2+.
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Figure 3.3.3 Sephadex G-75 filtration of isolated proteome incubated with 20 µM Zinquin acid
(ZQacid) followed by 500 µM DEA-NO. (A) Isolated proteome (10 µM Zn2+) was reacted with 20
µM ZQacid for 45 min followed by 500 µM DEA-NO for another 1 hour. The final reaction
mixture was separated using a Sephadex G-75 column, and the fractions were analyzed for both
fluorescence and zinc content. (B) Control: a parallel reaction was run at identical condition
with no DEA-NO added. (C) Comparison of the low molecular weight (LMW) fluorescence and
zinc content.
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3.3.3. Reaction of the whole LLC-PK1 cells with DEA-NO in the presence of TSQ.
Like Zinquin, TSQ also reacted with LLC-PK1 cells to form TSQ-Zn-Proteome ternary adducts, as
was evident from the fluorescence spectrum centered at around 470 nm. Incubation with 500
µM DEA-NO for 40 min caused a two-fold increase of fluorescence with the emission maximum
shifted at 480 nm (Figure 3.3.4 A), substantially more than obtained with Zinquin. However,
the change of fluorescence ratio at 490 nm to 470 nm was not as prominent as in the case of
Zinquin (Figure 3.3.4 B). As with ZQ, 10 µM TPEN was able to reduce the fluorescence to 32% of
the control value (100%), indicating the participation of Zn 2+ in the enhancement of
fluorescence followed by the addition of both TSQ and DEA-NO as well as the ability of TPEN to
reverse much of the control fluorescence enhancement by TSQ (Figure 3.3.4 C). Consistent with
the fluorescence enhancement, the sulfhydryl concentration reduced from 74 µM to 45 µM.
To characterize the fluorescent species, LLC-PK1 cells were incubated with 20 µM TSQ for 40
min followed by 500 µM DEA-NO for another 45 min. Cells were then washed, lysed and
centrifuged, and the resultant supernatant was fractionated using Sephadex G-75 column.
Contrary to the case of Zinquin, no detectable pool of low molecular weight fluorescence and
zinc as Zn(TSQ)2 was found in either DEA-NO treated or control cells (Figure 3.3.5 A & B).
Almost all the fluorescence and zinc was found in the high molecular weight proteome
fractions. The integrated fluorescence intensity of the high molecular weight fractions was 50%
greater than that of control (Figure 5C) and was aligned with the Zn 2+ concentrations in the
fractions. Moreover, the emission maxima of the proteomic fractions were found to be about
470 nm, indicative of TSQ-Zn-Proteome species. In contrast to the results with ZQ, these
findings indicate that Zn2+ mobilized by incubation with DEA-NO remains bound completely
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within the proteome in the presence of TSQ, forming ternary adducts instead of Zn(TSQ) 2.
Possibly, such adducts involve Zn2+ previously unavailable for reaction with TSQ that is still
associated with its original binding sites even after modification by NO (reaction 4).
Alternatively, Zn2+ at such sites might be redistributed to non-specific binding sites that
secondarily react with TSQ. Apparently, due to its lower affinity for Zn2+ relative to ZQ, TSQ
cannot compete with these newly formed adducts to generate Zn(TSQ)2 species.
Zn-S-Proteins + NO ⇌ Zn-NO-S-Proteins
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Figure 3.3.4 Reaction of LLC-PK1 cells with DEA-NO in the presence of TSQ. (A) Fluorescence
spectra of the reaction between 107 LLC-PK1 cells and 20 µM TSQ for 30 min followed by the
treatment with 500 µM DEA-NO for another 25 min. (B) The change of fluorescence ratio at 490
nm to 470 nm with time. (C) Percent enhancement of fluorescence upon addition of 500 µM
DEA-NO and its reversal by 10 µM TPEN.
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Figure 3.3.5 Sephadex G-75 filtration of LLC-PK1 cells incubated with TSQ followed by 500 µM
DEA-NO. (A) 108 LLC-PK1 cells were reacted with 500 µM DEA-NO for 45 min following 20 µM
TSQ for 40 min. The cells were lysed, centrifuged, and the supernatant was separated using a
Sephadex G-75 column. The fractions were analyzed for both fluorescence and zinc. (B) Control:
a parallel reaction was run at identical condition with no DEA-NO added. (C) Comparison of the
integrated fluorescence intensity of proteome.
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3.3.4. Reaction of isolated proteome with DEA-NO in the presence of TSQ.
The reaction of DEA-NO and TSQ with LLC-PK1 cells was examined in a simpler system. Isolated
proteome containing 10 µM Zn2+ was reacted with 20 µM TSQ for 40 min before 500 µM DEANO was added for another one hour. The reduction of sulfhydryl concentration by 41% (from
340 µM to 200 µM) indicated a significant extent of reaction between nitric oxide and
proteomic sulfhydryl groups (Figure 3.3.6). Upon fractionation using gel filtration, as was
observed in the reaction of whole cells, no measurable low molecular weight fluorescence or
zinc was found. That is, no Zn(TSQ)2 was formed in either DEA-NO treated and control
reactions.

Figure 3.3.6 Reaction of isolated proteome with DEA-NO in the presence of TSQ. Isolated
proteome (10 µM Zn2+) was reacted with 20 µM TSQ for 40 min followed by 500 µM DEA-NO
for another 1 hour. The final reaction mixture was separated using a Sephadex G-75 column,
and the fractions were analyzed for both fluorescence and zinc content.
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3.3.5. Reaction of isolated proteome with added Zn2+ in the presence of excess TSQ/ZQ.
The capacity of the proteome to bind adventitious Zn 2+ in the absence or presence of DEA-NO
and TSQ or ZQ was also investigated in order to probe the involvement of reactions 3 and 4 in
the previously observed reactions of Zn-proteins with DEA-NO and these sensors. Control
isolated proteome (8 µM Zn2+) was titrated with Zn2+ in the presence of excess ZQ or TSQ. The
fluorescence emission intensity centered at about 470 nm, due to the formation of ZQ/TSQZn●Proteome ternary adducts, increased in parallel with the concentration of added Zn 2+
(Figures 3.3.7 A & 3.3.8 A).

However, in both cases, the emission maximum remained

unchanged at 470 nm as Zn2+ was added to the proteome. Moreover, when the final reaction
mixtures were fractionated by Sephadex gel filtration, no measurable low molecular weight
fluorescence or zinc was detected with either fluorophore (Figures 3.3.7 B & 3.3.8 B). Thus, the
proteome contained extensive capacity to bind Zn2+ and form adducts with Zn2+ and either
sensor (reactions 5, 6).
Zn-Proteome + *Zn2+ ⇋

Zn-Proteome●*Zn

Zn-Proteome●*Zn + 2TSQ/ZQ ⇋ TSQ/ZQ-Zn-Proteome●Zn-TSQ/ZQ

(5)
(6)

Although consistent with the previous observations with TSQ in the absence or presence of
DEA-NO, these results differ from the findings about the reaction of cells or proteome with
DEA-NO in the presence of Zinquin. In that case, a red shifted emission maximum and a
detectable low molecular weight fluorescence and zinc pool indicated that some Zn(ZQ) 2 are
produced.
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The variance in outcome related to the absence or presence of DEA-NO suggested that the
behavior of ZQ depends on the existence and extent of modification of sulfhydryl groups that
participate in the adventitious proteomic binding of Zn2+ (*Zn2+) (reactions 7, 8) .
Zn-S-Proteome-SH + *Zn2+ ⇋ Zn-S-Proteome-S-*Zn2+

(7)

[RS- + ·NO  RS· + NORS· + ·NO  RSNO]
Zn-S-Proteome-S-*Zn2+ + 2 NO ⇋ NO-S-Proteome-S-NO + 2 Zn2+

(8)

As the number of adventitious binding sites for Zn 2+ is reduced through reaction with NO, the
formation of Zn(ZQ)2 becomes more favorable. However, with TSQ, its lower affinity for Zn 2+
prevents competitive generation of Zn(TSQ)2 even in the face of reduced numbers of proteomic
binding sites for Zn2+. According to this hypothesis, DEA-NO reduced the number of
adventitious binding sites by modifying important sulfhydryl groups. As a result, some, if not all,
of the labile Zn2+ can be sequestered as Zn(ZQ)2 (reaction 9).
NO-S-Proteome-S-NO + 2 Zn2+ + 4 ZQ ⇋ NO-S-Proteome-S-NO + 2 Zn(ZQ)2
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(9)

A.
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Figure 3.3.7 Titration of isolated proteome with ZnCl2 in the presence of Zinquin acid. (A)
Isolated proteome (8 µM Zn2+) was reacted with 20 µM Zinquin acid for 30 min (the
bottommost spectrum). Following on, the reaction mixture was titrated with the increasing
concentration of ZnCl2. (B) The change of fluorescence ratio at 490 nm to 470 nm. (C) The final
reaction mixture from (A) was fractionated using Sephadex gel filtration, and the eluted
fractions were analyzed for both fluorescence and zinc content.
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Figure 3.3.8 Titration of isolated proteome with ZnCl2 in the presence TSQ. (A) Isolated
proteome (8 µM Zn2+) was reacted with 20 µM TSQ for 30 min (the bottommost spectrum).
Following on, the reaction mixture was titrated with the increasing concentration of ZnCl 2. (B)
The change of fluorescence ratio at 490 nm to 470 nm. (C) The final reaction mixture from (A)
was fractionated using Sephadex gel filtration, and the eluted fractions were analyzed for both
fluorescence and zinc content.
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3.3.6. Reaction of isolated proteome with DEA-NO in the presence of FluoZin-3.
The reaction of isolated proteome (10µM Zn2+) with 500 µM DEA-NO was also monitored using
another Zn2+ sensor that does not form ternary complexes with Zn-proteins, FluoZin-3 (20 µM).
The absence of any fluorescence signal during the reaction of proteome and FluoZin-3 for 20
min indicated that Zn-proteome did not react with FluoZin-3 to form any ternary adduct.
However, the introduction of DEA-NO to the reaction mixture for 1 hour caused a gradual
increase of fluorescence throughout this period (Figure 3.3.9). Interestingly, addition of 10 µM
TPEN, a powerful Zn2+ chelator, at an intermediate time did not quench any of the enhanced
fluorescence. Instead, the fluorescence signal continued increasing. This datum suggested that
the increase of fluorescence was not due to the formation of Zn-FluoZin-3 complex, because its
fluorescence should have been reversed upon the addition of TPEN. The proteomic sulfhydryl
concentration was reduced by 41% (from 342 µM to 202 µM) after the reaction of proteome
with DEA-NO. In a separate experiment, upon fractionation of the final reaction mixture of
proteome (10 µM Zn2+), 20 µM FluoZin-3 and 500 µM DEA-NO using a Sephadex G-75 column,
no Zn-FluoZin-3 complex was found (Figure 3.3.10) meaning FluoZin-3 does not chelate
proteomic Zn2+.
To investigate the source of this fluorescence enhancement, 20 µM FluoZin-3 was reacted with
500 µM DEA-NO for 1 hour followed by 10 µM TPEN for another 10 min. A gradual increase of
fluorescence even larger than in the proteome experiment was observed. Again, 10 µM TPEN
could not reverse the intensification of the fluorescence. It was concluded that NO reacts with
FluoZin-3 with an increase of fluorescence, independent of its reaction with Zn2+. This finding is
of particular importance, because the reaction of NO and FluoZin-3 may confuse the
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researchers studying the induction of zinc release by nitric oxide in the presence of FluoZin-3,
unless not confirmed by TPEN.

3.3.7. Reaction of isolated proteome with DEA-NO prior to FluoZin-3.
Isolated proteome containing 5 µM Zn2+ was incubated with 500 µM DEA-NO for an hour and
subsequently, 20 µM FluoZin-3 was added for another 30 min. Fluorescence slowly increased
with time and 10 µM TPEN did not reverse the fluorescence (Figure 3.3.11 A). This again
suggests that the fluorescence enhancement is due not to the reaction of FluoZin-3 with
proteomic Zn2+, rather to that of FluoZin-3 and nitric oxide.
When the final reaction mixture of another experiment – reaction of isolated proteome (5 µM
Zn2+) pre-incubated with 500 µM DEA-NO for an hour followed by 20 µM FluoZin-3 – was
fractionated using Sephadex G-75 column, neither high molecular weight fluorescence nor low
molecular weight Zn-FluoZin3 was obtained (Figure 3.3.11 B).
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Figure 3.3.9 Reaction of isolated proteome with DEA-NO in the presence of FluoZin-3.
Isolated proteome (10 µM Zn2+) was reacted with 20 µM FluoZin-3 for 20 min followed by 500
µM DEA-NO for another hour. Finally 10 µM TPEN was added for 10 min. As control
experiment, 20 µM FluoZin-3 in 20 mM Tris (pH 7.4) was reacted with 500 µM DEA-NO for an
hour followed by 10 µM TPEN for another 10 min. The arrow indicates the time of TPEN
addition.
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Figure 3.3.10 Sephadex gel filtration of proteome incubated with DEA-NO in the presence of
FluoZin-3. Proteome (10 µM Zn2+) was reacted with 20 µM FluoZin-3 for 20 min. Subsequently,
500 µM DEA-NO was introduced into the reaction mixture for an hour. Following on, the final
reaction mixture was fractionated using Sephadex G-75 gel filtration chromatography. The
fractions eluted with 20 mM degassed Tris buffer at pH 7.4 were analyzed for fluorescence and
zinc content.
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Figure 3.3.11 Reaction of isolated proteome (5 µM Zn2+) with 500 µM DEA-NO followed by 20
µM FluoZin-3. (A) Proteome was incubated with 500 µM DEA-NO for one hour before 20 µM
FluoZin-3 was introduced for another 30 min. At this time point, 10 µM TPEN was added for an
additional 15 min. (B) Sephadex G-75 fractionation of the final reaction mixture of isolated
proteome pre-incubated with 500 µM for an hour followed by 20 µM FluoZin-3.
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3.3.8 Stability of Zn-FluoZin3 in the presence of proteome
The ability of FluoZin-3 to sense mobilized Zn2+ in the context of proteomic environment was
investigated by titrating isolated proteome (12 µM Zn 2+) with added Zn2+ in the presence of 10
µM FluoZin-3. Unexpectedly, no significant change in fluorescence was observed until about 1012 µM Zn2+ was added (region I), whereas a simple control titration of 10 µM FluoZin-3 in 20
mM Tris buffer (pH 7.4) with Zn2+ reached the maximum fluorescence at stoichiometric amount
of added Zn2+ (Figure 3.3.12 A). This indicated that the initial 10-12 µM Zn2+ was buffered by
various high affinity adventitious binding sites for Zn2+ within the proteome (Reaction 18), that
outcompeted FluoZin-3, a relatively high affinity Zn2+ sensor with Kd of 1.510-8 M, for the
added Zn2+.1, 2 However, as the added Zn2+ concentration was increased, fluorescence started
increasing gradually (region II), suggesting the competition between relatively lower affinity
proteomic adventitious sites and FluoZin-3 for the added Zn2+. Despite the enhancement at
higher added Zn2+ concentration, the maximum fluorescence in this experiment never reached
that of control titration, which might be due to the possible lower quantum yield of Zn-FluoZin3 complex in proteomic environment. The result of this experiment is particularly interesting,
because it shows that the mobilized Zn2+ resulting from the reaction of nitric oxide and
proteomic sulfhydryl groups in the presence of FluoZin-3 will be picked up by various high
affinity adventitious proteomic binding sites instead of FluoZin-3, unless a very high
concentration of Zn2+ is mobilized to saturate those adventitious sites before being sensed by
FluoZin-3. The dissociation constant (Khigh) of these high affinity adventitious sites
corresponding to region I was calculated to be in the order of 10-10 M. The calculation
considered 15 µM Zn2+ as the end point of the titration of the high affinity binding sites. The
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equilibrium constant (K) of the equation 10 was calculated, and then plugged into the equation,
K = KZn-FluoZin3 / KProteomeZn, to find the dissociation constant of the high affinity sites, KProteomeZn.
The dissociation constant of FluoZin-3, KZn-FluoZin3, was considered to be 1.5 x 10-8 M.
ProteomeZn + FluoZin3  Zn-FluoZin3 + Proteome

(10)

K = ([Zn-FluoZin3]*[Proteome]) / ([ProteomeZn]*[FluoZin3])

(11)

The dissociation constant (Kweak) of the proteome with weaker Zn2+ binding affinity
corresponding to region II was also calculated. The equilibrium concentrations of proteome and
proteomeZn were represented by the following equations.
[Proteome] = [CTotal proteome – (Cadded Zn2+ - ((F-Fmin)/(Fmax – Fmin))CTotal FZ-3)]
[ProteomeZn] = [Cadded Zn2+ - ((F-Fmin)/(Fmax – Fmin))CTotal FZ-3],
where C represents concentration, F fluorescence and FZ-3 FluoZin-3. Fmax and Fmin were taken
as 7000 and 336 (corresponding to 15 µM added Zn 2+) fluorescence units, respectively. By
substituting [Proteome] and [ProteomeZn] in equation 11, the equilibrium constant (Kweak)
becomes as follows.
Kweak = b [(CTotal proteome / (Cadded Zn2+ - a CTotal FZ-3)) – 1]

(12)

where b = (F-Fmin) / (Fmax – F) and a = F-Fmin / Fmax - Fmin. The equation 12 containing two
unknowns, Kweak and CTotal proteome, was solved for the added Zn2+ concentrations of 60, 70, 80
and 90 µM, and the average Kweak was found to be on the order of 10-7 M.
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The finding of the proteome’s high zinc buffering capacity indicates that observing Zn2+
mobilization using FluoZin-3 depends not only on the release of Zn2+ but also masking other
adventitious sites that have high affinity for Zn2+.
The ability of proteome to outcompete FluoZin-3 for Zn2+ was further studied in another way.
10 µM Zn-FluoZin-3 complex was titrated by isolated proteome (13 µM Zn2+). As expected,
initial fluorescence of Zn-FluoZin-3 decreased immediately by about 21% as 365 µg/mL of
proteome (final concentration) containing 1.2 µM Zn2+ (final concentration) was added (Figure
3.3.12 B).
(Zn)-Proteome-SH + Zn2+ ⇋ (Zn)-Proteome.*Zn
(Zn)-Proteome-S.*Zn + FluoZin-3 ⇋ (Zn)-Proteome-SH + *Zn-FluoZin-3
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Figure 3.3.12 Stability of Zn-FluoZin3 in the presence of proteome. (A) Isolated proteome (12
µM Zn2+) was incubated with 10 µM FluoZin-3 for 15 min. The reaction mixture was then
titrated with increasing concentration of ZnCl2. (B) 10 µM Zn-FluoZin-3 complex in Tris (pH 7.4)
was titrated with isolated proteome (13 µM Zn2+).
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3.4 Zinc buffering of proteome and proteomic components responsible for it
According to figure 3.3.11 A, in the titration of isolated proteome (12 µM Zn 2+) with Zn2+ in the
presence of 10 µM FluoZin-3, about 10 µM Zn2+ had to be added before any detectable ZnFluoZin3 was formed. This indicated that the initial 10 µM Zn2+ bound to the various proteomic
zinc binding sites having higher for Zn2+ affinity than FluoZin-3. This flat region where no
fluorescence was seen was referred to as ‘zinc buffering region I’. We wanted to investigate the
proteomic sites that possess higher affinity for added Zn2+ than FluoZin3. Since many of the zinc
binding sites in Zn-proteins utilize sulfhydryl groups as binding ligands, perhaps along with
other groups, that coordinate Zn2+, we hypothesized that the added Zn2+ binds to proteomic
sulfhydryl groups and create the zinc buffering phenomenon. To test this hypothesis, proteome
was incubated with different thiol binding agents, such as N-ethylmaleimide (NEM),
diethylamine NONOate (DEA-NO) and 5,5-dithio-bis-(2-nitrobenzoic acid) (DTNB), followed by
titration of the incubated proteome with Zn2+ in the presence of FluoZin-3 and Newport Green.

Figure 3.4.1 Reaction of N-ethylmaleimide (NEM) with thiolate anion
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Figure 3.4.2 Reaction of DTNB with sulfhydryl group of a thiol

3.4.1 Titration of proteome incubated with N-ethylmaleimide (NEM) with Zn2+ in the presence
of FluoZin-3
Proteome containing 10 µM Zn2+ was incubated with 500 µM NEM for an hour. Following the
incubation, 10 µM FluoZin-3 was added to the reaction mixture for 15 min. The reaction
mixture was subsequently titrated with the increasing concentration of ZnCl 2. The titration of
proteome with ZnCl2 in the presence of 10 µM FluoZin-3 without NEM incubation was used as
control experiment. As zinc was added to the NEM treated proteome, fluorescence started
increasing immediately, as opposed to in control experiment where about 15 µM Zn2+ had to be
added before any increase of fluorescence could be seen (Figure 3.4.3). Evidently, 500 µM NEM
completely neutralized the initial zinc buffering capacity of proteome. The emission maximum
of the fluorescence spectra at 520 nm suggested the formation of Zn-FluoZin3 complex. The
loss of initial zinc buffering capacity of proteome following 500 µM NEM incubation can be
explained as follows: NEM reacted with the proteomic sulfhydryl groups and as such blocked
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the binding sites for the added zinc. Therefore, the added zinc was available to be complexed
by FluoZin-3 and to form Zn-FluoZin3 with an enhancement of fluorescence. However, during
the second phase of the reaction (after 15 µM ZnCl2 was added), the change of fluorescence
was found to parallel that of the control suggesting that sulfhydryl groups were not the
predominant functional groups that bind Zn2+ in this phase.
Control:
Phase 1: Proteome-SH + Zn2+  Proteome-S-Zn
Phase 2: Proteome.Zn + FluoZin3  Proteome + Zn-FluoZin3
NEM:
Phase 1: Proteome-SH + NEM  Proteome-S-NEM
Zn2+ + FluoZin3  Zn-FluoZin3
Phase 2: Proteome.Zn + FluoZin3  Proteome + Zn-FluoZin3
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Figure 3.4.3 Titration of proteome incubated with N-methyl maleimide (NEM) with ZnCl2 in
the presence of FluoZin-3. (A) Fluorescence spectra of the titration of proteome (10 µM Zn 2+)
incubated with 500 µM NEM for an hour with ZnCl2 in the presence of 10 µM FluoZin-3. (B)
Change of fluorescence at 520 nm with the increasing concentration of ZnCl2. The control
experiment involves the titration of proteome without NEM incubation with ZnCl 2 in the
presence of 10 µM FluoZin-3. (C) The change of sulfhydryl concentration of proteome upon
NEM incubation.
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3.4.2 Titration of proteome incubated with N-ethylmaleimide (NEM) with ZnCl2 in the
presence of Newport Green (NPG)
As we have seen, the modification of proteomic sulfhydryl groups by NEM abolished the strong
zinc binding affinity of proteome and thus FluoZin-3 could in part outcompete proteome for the
added Zn2+, we repeated the experiment with a weaker zinc sensor Newport Green (NPG).
Possessing low affinity for Zn2+ (KD  10-6 µM), Newport Green cannot effectively compete with
the proteome’s higher affinity binding sites for added Zn 2+. According to the control experiment
in Figure 3.4.4, when isolated proteome containing 5 µM Zn2+ was titrated with the increasing
concentration of ZnCl2 in the presence of 10 µM Newport Green, about 25 µM Zn2+ had to be
added before NPG was able to bind Zn2+ with some enhancement of fluorescence. Newport
green could not compete with proteome for the initial 25 µM Zn 2+. During the second phase of
the reaction, a competition also existed between the proteome’s moderate affinity zinc binding
sites and Newport Green that resulted a gradual increase of fluorescence. However, when the
proteome (5 µM Zn2+) was incubated with 500 µM NEM and then titrated with ZnCl 2 in the
presence of 10 µM NPG, proteome’s zinc buffering capacity was significantly reduced.
Fluorescence enhancement due to the formation of Zn-NPG complex was observed after 10 µM
ZnCl2 was added, as opposed to about 25 µM in the control experiment. Since a slight red shift
in the emission maximum was observed, the possibility of the formation of ProteomeZn-NPG
could not be ruled out. The noticeable loss of proteome’s zinc buffering capacity following
incubation with NEM further implicated sulfhydryl groups in the proteomic competition with
the sensor for Zn2+.
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Figure 3.4.4 Titration of proteome incubated with N-methyl maleimide (NEM) with ZnCl2 in
the presence of Newport Green (NPG). (A) Fluorescence spectra from the titration of proteome
(5 µM Zn2+) incubated with 500 µM NEM with ZnCl2 in the presence of 10 µM Newport Green.
(B) [Control]: Isolated proteome (5 µM Zn2+) was incubated with 10 µM NPG for 15 min, and
then titrated with the increasing concentration of ZnCl2. [NEM]: Proteome (5 µM Zn2+) was
reacted with 10 µM NPG for 15 min followed by 500 µM NEM for another one hour.
Subsequently, the final reaction mixture was titrated with ZnCl2. [NPG + Zn]: 10 µM NPG in 20
mM Tris (pH 7.4) was titrated with ZnCl2. (C) The initial buffering region.
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3.4.3. Titration of proteome incubated with 5,5-dithio-bis-(2-nitrobenzoic acid) (DTNB) with
ZnCl2 in the presence of FluoZin-3.
The involvement of proteomic sulfhydryl groups in zinc buffering capacity of proteome was
investigated using another thiol binding reagent 5,5-dithio-bis-(2-nitrobenzoic acid) (DTNB).
Consistent with the results from the previous experiments with NEM, the strong zinc binding
affinity was obliterated in the DTNB treated proteome. According to figure 3.4.5, fluorescence
enhancement due to the formation of Zn-FluoZin3 complex was observed immediately after
Zn2+ was added. Since DTNB reacted with proteomic sulfhydryl groups and blocked their
reaction with the added Zn2+, FluoZin-3 was able to bind Zn2+ with an increment of
fluorescence. By contrast, in the control experiment sigmoidal curve was seen for the increase
of fluorescence with added Zn2+ indicating zinc buffering capacity of proteome.
Proteome-SH + DTNB  Proteome-S-TNB + TNB
Zn2+ + FluoZin-3  Zn-FluoZin3
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Figure 3.4.5 Titration of proteome incubated with 5,5-dithio-bis-(2-nitrobenzoic acid) (DTNB)
with ZnCl2 in the presence of FluoZin-3. (A) Fluorescence spectra of titration of proteome (6 µM
Zn2+) incubated with 5,5-dithio-bis-(2-nitrobenzoic acid) (DTNB) and 10 µM FluoZin-3 with the
increasing concentration of ZnCl2 (0-100 µM). (B) Change of fluorescence intensity with the
concentration of ZnCl2.
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3.5 Status of Zn-proteome at different phases in a cell cycle
Meeusen et al. reported that when LLC-PK1 cells were incubated with 30 µM TSQ for 30 min at
37 0C, the fluorescence in cells due to the formation of TSQ-Zn-Proteome ternary adduct was
asymmetric, i.e., some cells showed brighter fluorescence than others (Figure 3.5.1 A).65
Moreover, when 30 µM Zn2+ and 3 µM pyrithione was added to the TSQ incubated cells,
fluorescence enhancement was asymmetric as well (Figure 3.5.1 B). We hypothesized that this
asymmetric distribution of fluorescence was attributed to the cells being at different phases of
the cell cycle, where the cells synthesize varied quantities of zinc proteins and thus, different
concentrations of TSQ-Zn-proteome would be generated when incubated with TSQ. To test this
hypothesis, CCRF-CEM cells were incubated with different chemical blockers (Thymidine and
Nocodazole) to block the cells at different phases of the cell cycle and then reacted with
fluorescent sensors, such as TSQ and Zinquin. Thymidine blocks the cells at G1 phase, while
Nocodazole at G2/M phase.99-104 The synchronization of the cells was confirmed by flow
cytometry, which measures optical and fluorescence properties of single cells. 105-107 Cell
populations are sort out by the physical properties of the cells, such as size (represented by
forward angle light scattering) and intracellular complexity (represented by side scattering).
Cells are treated with fluorescent dyes which may bind or intercalate with cellular constituents
such as DNA or RNA. Stained cells suspended in buffer are drawn into a stream generated by a
surrounding sheath of isotonic fluid, which permit the cells to pass one at a time through an
interrogation point. At this point, the cells are intersected with a beam of monochromatic light
from a laser source. Based on the intensities of the emitted light, the cell populations are
resolved. We chose CCRF-CEM cells for this study because this is a suspension cell line, which
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was found to be easier for cell sorting by flow cytometry than an adherent cell line, such as LLCPK1 used by Meeusen for his experiments.

Figure 3.5.1 Fluorescence micrograph images of cellular Zn2+ observed after exposure to the
Zn2+ fluorophore TSQ. (A) LLC-PK1 cells incubated with 30 µM TSQ in DPBS for 30 min at 37 0C.
(B) Fluorescence increase of A after addition of 30 µM Zn 2+ and 3 µM pyrithione for 1 min. (C)
Fluorescence reduction of B following addition of 100 µM TPEN for 10 min.

3.5.1 Cell viability assay
Cell viability of CCRF-CEM cells treated with 2 mM thymidine or 100 ng/mL nocodazole for 24
hours and control (untreated) cells was determined with Trypan Blue exclusion assay.
Thymidine treated cells were found to be 90% viable, whereas nocodazole incubated cells
showed about 80% viability. Control cells were almost 100% viable.
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3.5.2 Reaction of TSQ and CCRF-CEM cells blocked at G1 phase by thymidine
In order to block the cells at G1 phase, CCRF-CEM cells were treated with 2 mM thymidine for
24 hours, and the synchronization of the cells at G1 phase was confirmed using Flow
Cytometry. 13.05 x 106 thymidine-blocked cells were washed and resuspended in DPBS and
then reacted with 20 µM TSQ, which resulted in gradual increase of fluorescence centered at
470 nm indicating the formation of TSQ-Zn-Proteome (Figure 3.5.2 B). As a control experiment,
10.5 x 106 untreated cells distributed throughout the cell cycle were reacted with 20 µM TSQ,
which also showed fluorescence intensity with an emission maximum of 470 nm (Figure 3.5.2
A). However, when the fluorescence intensity was normalized, the intensity per million cells for
thymidine-blocked cells (187 units) were found to be 42% greater than that (132 units) of
control cells. This greater fluorescence intensity for CCRF-CEM cells blocked at G1 phase
suggests that cells at G1 phase synthesize greater concentration of zinc proteins than at other
phases of a cell cycle and that the greater availability of zinc proteins allows TSQ to generate
more TSQ-Zn-Proteome ternary adduct. After the reaction, both control and thymidine-blocked
cells were sonicated, centrifuged and the cell lysates were analyzed for fluorescence.
Consistent with the fluorescence intensities of the whole cells, the cell lysates also showed
unequal normalized fluorescence (Figure 3.5.3). The cell lysate from the thymidine-blocked
cells (170 fluorescence units per million cells) displayed 70% greater fluorescence intensities
than that from the control cells (100 fluorescence units per million cells). Consequently, both
the whole cells and the cell lysates support the hypothesis that cells at G1 phase synthesize a
greater concentration of zinc proteins than at other stages of the cell cycle.
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Figure 3.5.2 Reaction of TSQ and CCRF-CEM cells blocked at G1 phase by thymidine. (A)
Control: 10.5 x 106 CCRF-CEM cells were harvested, resuspended in DPBS and then reacted with
20 µM TSQ for 20 min. The fluorescence spectra was recorded every 5 min. (B) 13.05 x 10 6
CCRF-CEM cells incubated with 2 mM thymidine for 24 hours were harvested, resuspended in
DPBS and then reacted with 20 µM TSQ for 20 min. (C) Comparison of kinetics of both reaction.
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Figure 3.5.3 Fluorescence spectrum of the cell lysate collected from CCRF-CEM cells (TSQ). Cells
were incubated with 2 mM thymidine for 24 hours and then reacted with 20 µM TSQ for 20
min. Cell lysates of both control and thymidine blocked cells were collected by the sonication of
the cells followed by centrifugation.
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3.5.3 Reaction of Zinquin (ZQ) and CCRF-CEM cells blocked at G1 phase by thymidine
CCRF-CEM cells synchronized at G1 phase by thymidine were also reacted with Zinquin (ZQ).
18.55 x 106 cells blocked at G1 phase by 2 mM thymidine for 24 hours were washed and
resuspended in DPBS, and subsequently reacted with 20 µM Zinquin (Figure 3.5.4 B). Like TSQ,
Zinquin also formed ZQ-Zn-Proteome ternary adduct, as evident from the gradual enhancement
of fluorescence intensity with a max of 470 nm. The reaction of 16.75 x 106 untreated cells with
20 µM Zinquin was also performed as a control experiment. The control cells, like thymidineblocked cells, also showed fluorescence intensity centered at 470 nm (Figure 3.5.4 A). However,
as the fluorescence intensities for both control and synchronized cells were normalized, the
intensity from blocked cells (75 fluorescence units per million cells) was 47% greater than that
from untreated cells (51 units per million cells). The cells lysates from both control and
synchronized cells were collected following the reaction. As the fluorescence of the lysates was
read, they also showed unequal normalized fluorescence intensities. The cell lysate from
thymidine-blocked cells gave 139 fluorescence units per million cells, as opposed to 103 units
for the cell lysate from control cells – 35% greater fluorescence intensity for the synchronized
cells (Figure 3.5.5). The reaction of CCRF-CEM cells blocked at G1 phase with Zinquin once again
supports the hypothesis that cells produce more zinc proteins during G1 phase of its life cycle
than at other phases.
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Figure 3.5.4 Reaction of Zinquin (ZQ) and CCRF-CEM cells blocked at G1 phase by thymidine.
(A) Control: 16.75 x 106 CCRF-CEM cells were harvested, resuspended in DPBS and then reacted
with 20 µM ZQ for 25 min. (B) 18.55 x 106 CCRF-CEM cells incubated with 2 mM thymidine for
24 hours were harvested, resuspended in DPBS and then reacted with 20 µM ZQ for 25 min. (C)
Comparison of kinetics of both reactions.
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Figure 3.5.5 Fluorescence spectrum of the cell lysate collected from CCRF-CEM cells (ZQ). Cells
were incubated with 2 mM thymidine for 24 hours and then reacted with 20 µM Zinquin ethyl
ester (ZQee) for 20 min. Cell lysates of both control and thymidine blocked cells were collected
by the sonication of the cells followed by centrifugation.
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3.5.4 Reaction of TSQ and proteome isolated from CCRF-CEM cells blocked at G1 phase by
thymidine
We have seen that the reaction of CCRF-CEM cells blocked at G1 phase by thymidine with TSQ
or Zinquin, when compared with the untreated cells, suggests that cells synthesize greater
concentration of Zn-proteins during G1 phase than any other phases of the cell cycle. To further
verify this hypothesis, proteome was isolated from CCRF-CEM cells treated with 2 mM
thymidine for 24 hours and then reacted with 20 µM TSQ. As the reaction progressed,
fluorescence centered at 470 nm increased, indicative of the formation of TSQ-Zn-Proteome
ternary adducts (Figure 3.5.6 B). The control experiment was done with the proteome isolated
from the untreated CCRF-CEM cells. The reaction of control proteome with 20 µM TSQ also
displayed fluorescence enhancement with max of 470 nm (Figure 3.5.6 A). Again, consistent
with the whole cells results, the normalized fluorescence intensity resulting from the reaction
of proteome and TSQ was significantly different for control cell proteome and thymidineblocked cell proteome. The fluorescence intensity per million cells synchronized in G1 phase
was found to be double of that for control cells (Table 3.5.1). Moreover, the zinc content per
million cells for thymidine-blocked cells was also 50% greater than that for untreated cells
(Table 3.5.1). Therefore, the hypothesis that cells at G1 phase synthesize greater concentration
of zinc proteins than at other phases of cell cycle is supported by experiments with both whole
cells and isolated proteome.
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Figure 3.5.6 Reaction of TSQ and proteome isolated from CCRF-CEM cells blocked at G1 phase
by thymidine. (A) Control: 1.25 x 108 cells were harvested, sonicated and centrifuged. The cell
lysate was then loaded onto a Sephadex G-75 column to collect the proteome. Following on,
proteome was reacted with 20 µM TSQ for an hour. (B) Proteome was isolated from 1.2 x 108
CCRF-CEM cells treated with 2 mM thymidine for 24 hours. Isolated proteome was
subsequently reacted with 20 µM TSQ for an hour. (C) Comparison of kinetics of both reactions.
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Table 3.5.1: Comparison of the normalized fluorescence intensities from TSQ reaction and zinc
contents of proteome isolated from control (untreated) CCRE-CEM cells and thymidine blocked
cells
Ratio
(Blocked/control)
Fluorescence intensity per
million cells (A.U.)
Zinc content per million cells
(nmol)

Control

29

Blocked

57

Control

0.10

Blocked

0.16
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1.5

3.5.5 Reaction of Zinquin (ZQ) and proteome isolated from CCRF-CEM cells blocked at G1
phase by thymidine
The reaction of proteome isolated from CCRF-CEM cells that had been synchronized at G1
phase was investigated with Zinquin (ZQ) as well. To do this, proteome was collected from 1.2 x
108 CCRF-CEM cells treated with 2 mM thymidine for 24 hours, and subsequently reacted with
20 µM Zinquin. Like TSQ, Zinquin also reacted with isolated proteome with an enhancement of
fluorescence with an emission maximum of 470 nm (Figure 3.5.7 B). Control proteome isolated
from 1.25 x 108 untreated CCRF-CEM cells was also reacted with 20 µM Zinquin. The control
reaction also showed gradual increase of fluorescence with max of 470 nm (Figure 3.5.7 A). The
results were comparable to those of the TSQ experiment. The normalized fluorescence intensity
from the reaction of proteome isolated from CCRF-CEM cells blocked at G1 phase (41
fluorescence units per million cells) was found to be almost double that for control (untreated)
cells (22 units per million cells) (Table 3.5.2). The normalized zinc content was also found to be
about 40% greater in case of synchronized cells – 0.15 nmol per million cells as opposed to 0.11
nmol in control cells (Table 3.5.2). This experiment further strengthens the hypothesis that
more proteome-bound Zn exists in cells at G1 phase than at any other phases of the cell cycle.
Since ZQ and TSQ qualitatively bind to different Zn-proteins, these results imply that a broad
range of Zn-proteins undergoes concentration changes during the course of the cell cycle.
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Figure 3.5.7 Reaction of Zinquin (ZQ) and proteome isolated from CCRF-CEM cells blocked at
G1 phase by thymidine. (A) Control: 1.25 x 108 cells were harvested, sonicated and centrifuged.
The cell lysate was then loaded onto a Sephadex G-75 column to collect the proteome.
Following on, proteome was reacted with 20 µM Zinquin for an hour. (B) Proteome was
isolated from 1.2 x 108 CCRF-CEM cells treated with 2 mM thymidine for 24 hours. Isolated
proteome was subsequently reacted with 20 µM Zinquin for an hour. (C) Comparison of kinetics
of both reactions.
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Table 3.5.2: Comparison of the normalized fluorescence intensities from Zinquin reaction and
zinc contents of proteome isolated from control (untreated) CCRE-CEM cells and thymidine
blocked cells

Ratio
(Blocked/Control)
Fluorescence intensity per
million cells (A.U.)
Zinc content per million cells
(nmol)

Control

22

Blocked

41

Control

0.11

Blocked

0.15
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1.9

1.4

3.5.6 Reaction of TSQ and proteome isolated from CCRF-CEM cells blocked at G2/M phase by
nocodazole
The reactions of CCRF-CEM cells synchronized at G1 phase by thymidine or the isolated
proteome from blocked cells with TSQ or Zinquin showed that cells synthesize more Zn-proteins
in G1 phase than in other phases of the cell cycle. Next, we wanted to investigate the status of
cellular zinc proteins at other phases of the cell cycle to extend the above findings. Logically,
cells should produce fewer number of Zn-proteins at other phases than at G1 phase in order
that the average for the divinding cell population be less than for G1. To probe this, another cell
blocker nocodazole was chosen, which blocks the cells at G2/M phase. CCRF-CEM cells were
treated with 100 ng/mL nocodazole for 24 hours to synchronize the cells at G2/M phase. Cell
synchronization at G2/M phase was verified using Flow Cytometry. For this experiment,
proteome was isolated from 5.5 x 107 CCRF-CEM cells treated with 100 ng/mL nocodazole for
24 hours, and then reacted with 20 µM TSQ. As expected, fluorescence enhancement with an
emission maximum of 470 nm was found (Figure 3.5.8 B). Proteome was isolated from 5.8 x 107
untreated cells and reacted with 20 µM TSQ as a control experiment (Figure 3.5.8 A). When
normalized, the fluorescence intensity for the blocked cells at G2/M phase (32 fluorescence
units per million cells) was found to be about half of that for control cells (69 fluorescence units
per million cells) (Table 3.5.3). The normalized zinc content in synchronized cells was also found
to be 67% of the control – 0.08 nmol zinc per million cells as opposed to 0.12 nmol in control
cells (Table 3.5.3). These results indicate that cells at G2/M phase synthesize less zinc
containing proteins than at other phases of the cell cycle.
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Figure 3.5.8 Reaction of TSQ and proteome isolated from CCRF-CEM cells blocked at G2/M
phase by nocodazole. (A) Control: 5.8 x 107 cells were harvested, sonicated and centrifuged.
The cell lysate was then loaded onto a Sephadex G-75 column to collect the proteome.
Following on, proteome was reacted with 20 µM TSQ for 30 min. (B) Proteome was isolated
from 5.5 x 107 CCRF-CEM cells treated with 100 ng/mL nocodazole for 24 hours. Isolated
proteome was subsequently reacted with 20 µM TSQ for 30 min. (C) Comparison of kinetics of
both reactions.
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Table 3.5.3: Comparison of the normalized fluorescence intensities from TSQ reaction and zinc
contents of proteome isolated from control (untreated) CCRE-CEM cells and nocodazole
blocked cells
Ratio
(Blocked/control)
Fluorescence intensity per
million cells (A.U.)
Zinc content per million cells
(nm)

Control

69

Blocked

32

Control

0.12

Blocked

0.08
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0.5

0.67

3.5.7 Reaction of Zinquin (ZQ) and proteome isolated from CCRF-CEM cells blocked at G2/M
phase by nocodazole
The previous experiment - the reaction of TSQ and proteome collected from CCRF-CEM cells
synchronized at G2/M phase by nocodazole - was compared with another that utilized ZQ in
place of TSQ. In doing so, proteome was isolated from 5.8 x 107 CCRF-CEM cells treated with
100 ng/mL nocodazole for 24 hours and then reacted with 20 µM Zinquin for 30 min. As
expected, gradual increase of fluorescence centered at 470 nm was observed due to formation
of ZQ-Zn-Proteome ternary complex (Figure 3.5.9 B). The result of this experiment was
compared with a control experiment in which 20 µM Zinquin was reacted with proteome
isolated from 5.5 x 107 untreated CCRF-CEM cells (Figure 3.5.9 A). Like TSQ, Zinquin reaction
also showed that the normalized fluorescence intensity and zinc content are dissimilar for
synchronized and control cells. The fluorescence intensity per million cells for blocked cells at
G2/M phase (19 arbitrary units) was found to be 50% of that for control cells (40 arbitrary units)
(Table 3.5.4). Consistently, zinc content per million cells for synchronized cells (0.08 nmol) was
67% of that for control cells (0.12 nmol) (Table 3.5.4). This experiment again indicates that cells
make relatively fewer number of zinc proteins during G2/M phase than at other phases of the
cell cycle.
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Figure 3.5.9 Reaction of Zinquin (ZQ) and proteome isolated from CCRF-CEM cells blocked at
G2/M phase by nocodazole. (A) Control: 5.8 x 107 cells were harvested, sonicated and
centrifuged. The cell lysate was then loaded onto a Sephadex G-75 column to collect the
proteome. Following on, proteome was reacted with 20 µM Zinquin (ZQ) for 30 min. (B)
Proteome was isolated from 5.5 x 107 CCRF-CEM cells treated with 100 ng/mL for 24 hours.
Isolated proteome was subsequently reacted with 20 µM Zinquin (ZQ) for an hour. (C)
Comparison of kinetics of both reactions.
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Table 3.5.4: Comparison of the normalized fluorescence intensities from Zinquin reaction and
zinc contents of proteome isolated from control (untreated) CCRE-CEM cells and thymidine
blocked cells
Ratio
(Blocked/Control)
Fluorescence intensity per
million cells (A.U.)
Zinc content per million cells
(nmol)

Control

40

Blocked

19

Control

0.12

Blocked

0.08

157

0.5

0.67

4. DISCUSSION
Zinc is involved in a wide array of biological functions, including its structural and catalytic roles
in various Zn-proteins.1,

2

Recent studies have revealed that Zn2+ also serves as a signaling

molecule and a secondary messenger.41, 42 With the aim of studying the zinc trafficking across
the cell membrane and within the cell, a number of fluorescent sensors with a wide range of
stability constants have been designed and synthesized.1, 2 Conventionally, the appearance of a
fluorescence microscopic signal following the incubation of cells with a cell permeable sensor,
and its disappearance in the presence of the powerful membrane permeant chelator, TPEN, are
interpreted as indicating the presence of labile, available Zn2+ in the cellular process under
study. However, in most cases, the chemical interaction between the fluorescent dye and
various cellular components, and the sensor’s influence on the equilibria between the Znproteins and the sensor itself have not been thoroughly studied. If the available free Zn 2+
concentration is not comparable with the stability constant and the concentration of the sensor
used, the conclusions drawn from the studies that employed the sensor may be ambiguous.
Therefore, the biological chemistry of these fluorescent sensors needs to be properly
understood.
A number of studies have used the fluorescent sensor Newport Green (NPG) to image
intracellular labile Zn2+.67-72 A sensor with a low Zn2+ binding affinity (Kd  10-5-10-6 M), NPGA, its
acid form, binds Zn2+ in vitro with a 1:1 stoichiometry and displays a two-fold enhancement of
fluorescence upon binding Zn2+, which is readily reversed by TPEN. However, some limitations
of NPG include its high background fluorescence and the unaltered emission maximum of 530
nm following Zn2+ binding. Moreover, both NPGA and Zn-NPGA show non-linear growth of
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fluorescence at increasing concentrations, possibly, due to the -stacking of fluorescein
reporters of the sensor. This property complicates its use in quantitative measurements. In
addition, because of its small binding constant for Zn 2+, it may encounter cellular ligands,
including proteins and small molecules such as glutathione, that compete with NPG for
intracellular labile Zn2+. This study examined the effectiveness of NPG as a zinc sensor within
the cellular environment.
When LLC-PK1 cells were reacted with the cell permeable, non-fluorescent ester form NPGE, a
slow increase of fluorescence was observed, which continued growing despite the addition of
TPEN. This suggested that the fluorescence enhancement originated from the slow hydrolysis of
the non-fluorescent ester NPGE to the fluorescent acid NPGA catalyzed by cellular esterases.
NPGA did not react with the native distribution of Zn2+ to produce any measurable Zn-NPG or
NPG-Zn-Proteome ternary adduct, unlike TSQ and Zinquin (ZQ).50,
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Strangely, much of the

NPGA generated following hydrolysis of NPGE was found in the extracellular medium, indicating
the efflux of NPGE or NPGA by some unknown mechanism. This finding indicated that the
fluorescence enhancement attributed to the imaging of intracellular Zn 2+ reported in some
studies might involve the extracellular Zn2+.
Filtration the cell lysate collected from LLC-PK1 cells incubated with NPGE showed that NPGA
made non-specific interactions with proteome, as majority of fluorescence was associated with
the high molecular weight retentate and was unaffected when TPEN was added. Similar results
obtained from the reaction of isolated proteome with NPGE or NPGA further supported the nonspecific interaction of NPGA with proteome. When reacted with individual Zn-proteins instead
of the whole proteome, such as alcohol dehydrogenase (Zn-ADH) and carbonic anhydrase (Zn159

CA), NPGE slowly converted to NPGE, accompanied by a slow increase of fluorescence, meaning
that both Zn-proteins acted as esterases which catalyzed the conversion. TPEN could not
reverse the course of fluorescence increase, which suggested that no NPG-Zn-ADH or NPG-ZnCA ternary adduct formed. However, filtration of the final reaction mixtures demonstrated that
NPGA interacted non-specifically with both Zn-ADH and Zn-CA, consistent with the proteome
results. By contrast, both TSQ and Zinquin (ZQ) form ternary adducts TSQ/ZQ-Zn-(CA/ADH) with
both Zn-proteins.50,
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Both NPGA and Zn-NPGA showed significant interaction with bovine

serum albumin, which has a well-defined zinc binding site, as well. As NPGA or Zn-NPGA was
reacted with BSA, a noticeable enhancement of fluorescence was observed and the emission
maximum shifted from 532 nm to 538 nm. Following filtration of the final reaction mixtures, all
of the fluorescence intensity was found associated with BSA, which further confirmed the
interaction of BSA and NPGA or Zn-NPGA. This random binding of NPGA to proteome, further
supported by the reactions with individual proteins, including alcohol dehydrogenase, carbonic
anhydrase and bovine serum albumin, is an undesired property of a cellular metal binding
sensor. A recent paper also reported the interaction of NPG with proteomic fractions following
gel filtration.108
From the reactions of NPG with the whole cells, isolated proteome and individual proteins, it
was concluded that NPG is not reactive with the static distribution of cellular zinc. Next,
proteome, including Zn-proteome, together with NPGA was titrated with Zn2+ to model the
cellular dynamic Zn2+ pool to examine if NPGA with its low zinc binding constant can bind to the
mobile Zn2+ within the proteomic environment. No Zn-NPGA formed even after the addition of
about five times Zn2+ concentration of the native proteome, meaning that proteome contains a
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large number of Zn2+ binding sites with zinc binding affinity much higher than NPG, which
effectively outcompete NPG for the added Zn2+ (reaction 1). This property of proteome is
referred to as its zinc buffering capacity.
Proteome + NPGA + Zn2+ ⇌ Proteome•Zn + NPGA

(1)

Beyond this buffering region, NPGA could weakly compete with the proteome, indicating that
proteome has additional binding sites with zinc binding stability constants comparable to NPG A
(reaction 2).
Proteome•Zn + NPGA ⇌ Proteome + Zn-NPGA

(2)

Proteome could also chelate Zn2+ from pre-incubated Zn-NPGA complex to form Proteome•Zn,
further substantiating its additional zinc binding sites with greater stability constants than NPG.
Together, these titration experiments implied that Zn-NPGA complex is not stable enough to
survive within the proteomic environment, where a large number of proteomic ligands can
outcompete NPGA for Zn2+. This finding is very significant, because it brings forth the question
of how NPGA acts an intracellular sensor to image mobile Zn2+ reported in many studies by
surpassing the high zinc buffering capacity of proteome. Possibly, the proteome’s zinc buffering
capacity is cellular compartment specific, i.e. the proteins with high zinc buffering capacity are
limited to certain cellular organelles such that NPGA can bind free or labile pool of Zn2+ in some
parts of the cell. However, when subcellular proteome, including cytosolic, mitochondrial and
nuclear proteome, were collected and subsequently, titrated with Zn 2+, buffering capacity was
observed in all of them, regardless of the compartment. Besides proteome, glutathione,
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another potential Zn2+ binding small molecule ligand that exists in mM concentration in
eukaryotic cells and has an apparent stability constant for Zn2+ at pH 7 of 104.2, also competed
with NPGA for Zn2+.81 In addition, Zn-NPGA showed weak stability in the presence of micromolar
concentration of glutathione, suggesting that there are plethora of potential ligands, both
proteome and small molecules, including glutathione, which compete with NPG A to bind labile
Zn2+. So under this circumstance, NPGA’s efficacy as an intracellular zinc sensor is questionable.
The finding that Zn-NPGA complex is inadequately stable observed from in vitro experiments
(proteome and glutathione) was in agreement with in vivo observations. When LLC-PK1 cells
pre-incubated with NPGE were treated with Zn(pyrithione)2, Zn2+ complexed with the ionophore
pyrithione, an immediate increase fluorescence was observed. However, the cell impermeable
strong Zn2+ chelator, EDTA, almost completely quenched the increased fluorescence, revealing
that the signal enhancement originated from extracellular Zn-NPGA formation. The extracellular
NPGA may have resulted from the efflux of NPGA following the conversion from NPGE described
earlier. Although pyrithione shuttled into cells a significant amount of Zn2+ - almost equal to
50% of the total proteomic Zn2+ concentration – the intracellular NPGA could not compete with
the cellular competitors to generate any Zn-NPGA, because no measurable intracellular
fluorescence enhancement could be detected. This experiment once again encourages the
possibility that the fluorescence enhancement which was attributed to intracellular Zn-NPGA
formation reported in various studies may partly originate from the extracellular Zn-NPGA.
To further substantiate the observation that NPGA cannot effectively compete with the
competitive proteomic and small molecule ligands for the mobile Zn 2+, isolated proteome pretreated with NPGA was reacted with two thiol binding reagents, a nitric oxide donor
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diethylamine NONOate (DEA-NO) and N-ethylmaleimide (NEM), which react with proteomic
sulfhydryl groups and liberate Zn2+ coordinated by thiolate ligands in native Zn-proteins.
Following the reaction with DEA-NO, no detectable Zn-NPGA was formed, implying that the
liberated Zn2+ from native Zn2+ binding sites was captured by competitive proteomic and/or
small molecule ligands. Interestingly, NPGA reacted independently with nitric oxide (NO)
accompanied by fluorescence enhancement and unaltered emission maximum, meaning that
NPGA acts also as a nitric oxide (NO) sensor. Therefore, previous studies that employed NPG A to
detect Zn2+ liberated upon reaction with nitric oxide might have to be re-examined, since the
fluorescence increase perhaps stemmed from NPGA’s binding to nitric oxide (NO), not from ZnNPGA.
The other thiol binding reagent NEM reacted with about 50% of the proteomic sulfhydryl
groups and resulted in a small increase of fluorescence. However, TPEN could only partially
reverse the fluorescence enhancement, indicating that an insignificant amount of Zn-NPGA had
formed. By contrast, Zinquin, a higher affinity zinc sensor than NPG, binds Zn 2+ mobilized from
proteome following the reaction with NEM as Zn(ZQ)2.83 Apparently, proteomic ligands bind the
newly liberated Zn2+ with higher affinity than NPGA, further questioning NPGA’s ability to image
free Zn2+ in the cellular environment.
Although a number of studies used NPG to image intracellular free Zn2+, this present work
questions the stability of Zn-NPGA in all cellular compartments. Newport Green, because of its
small stability constant for Zn2+, has to compete with a host of adventitious proteomic sites
with higher affinity for Zn2+. Therefore, these results bring into the question what pools of
intracellular or extracellular Zn2+ are imaged by Newport Green.
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Having found that Newport green with a modest stability constant for Zn 2+ cannot serve as a
good sensor for imaging Zn2+ within the cellular environment, next we studied the biological
chemistry of another fluorescent Zn2+ sensor Zinpyr-1 (ZP1) that has a stability constant higher
than Newport Green. The ZP1 structure possesses two di-(2-picolyl)amine chelators that bind
Zn2+ ions (Figure 1.2). It binds the first Zn2+ with much higher affinity (Kd 0.7 nM) but with very
weak fluorescence, while the weaker binding of the second Zn 2+ (Kd 85 µM) is associated with
much higher increase of fluorescence.1 Moreover, the half-saturated complex ZP1-Zn displays
an emission maximum of 535 nm, but shifts to 525 nm as the fully saturated complex ZP1(Zn) 2
is generated. Since the strong binding of first Zn2+ results in very weak fluorescence and the
weak binding of second Zn2+ gives larger fluorescence increase, the gradual binding of Zn 2+ to
ZP1 produces a sigmoidal shaped titration curve. This property – production of weak
fluorescence upon strong binding of the first Zn 2+ - makes its use as a cellular sensor
complicated.
The incubation of LLC-PK1 cells with ZP1 resulted in very weak fluorescence with an emission
maximum of 535 nm. Neither TPEN, a cell permeable strong Zn2+ chelator, nor EDTA, a cell
impermeable strong Zn2+ chelator, could quench the fluorescence. This apparently indicated no
reaction between ZP1 and intracellular, native Zn2+ or extracellular Zn2+. However, since the
strong binding of Zn2+ to ZP1 gives very weak fluorescence, it is difficult to conclude definitively
that no reaction occurred between ZP1 and cellular Zn 2+. When the cell lysate obtained
following the incubation of LLC-PK1 cells with ZP1 was separated using size exclusion
chromatography, a significant pool of high molecular weight fluorescence was observed that

164

co-existed with most of the Zn2+ concentration in the cell lysate. This suggested the formation
of ternary adduct, ZP1-Zn-Proteome, between ZP1 and native Zn-Proteome.
To further investigate the possibility of the formation of ZP1-Zn-Proteome ternary adduct, ZP1
was reacted with isolated Zn-Proteome. The fluorescence with 540 nm emission maximum
generated from the reaction was reduced by 44% by TPEN. Moreover, upon gel filtration of the
final reaction mixture of ZP1 and isolated Zn-proteome, the majority of the fluorescence was
found in the high molecular weight, proteome region. TPEN quenched the integrated
fluorescence intensity of the proteome fractions by about 25%. Together, these experiments
again pointed to the production of ZP1-Zn-Proteome ternary adduct.
As another evidence of its reaction with Zn-proteome, ZP1 displaced TSQ from TSQ-ZnProteome ternary adduct generated by the reaction of TSQ and Zn-Proteome and formed new
ternary adduct species ZP-Zn-Proteome. This was quite evident from the disappearance of
fluorescence intensity of TSQ-Zn-Proteome at 470 nm, and the emergence of 540 nm
fluorescence due to the formation of ZP1-Zn-Proteome. TPEN caused significant reduction of
the integrated fluorescence of proteome at 540 nm.
Besides its reaction with native Zn-proteome, ZP1 forms a ternary adduct, Proteome•Zn-ZP1,
with isolated proteome and added Zn2+ as well. As isolated proteome was titrated with Zn2+ in
the presence of ZP1, a progressive increase of fluorescence was observed immediately, which
resulted in a hyperbolic graph of fluorescence increase vs. added Zn 2+, unlike the titration of
ZP1 with Zn2+ that gives a sigmoidal shaped fluorescence vs. Zn 2+ binding curve due to the
unequal binding affinities of two Zn2+ ions for ZP1 and their distinct fluorescence properties.
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Moreover, throughout the titration the emission maximum remained unaltered at 535-540 nm.
Gel filtration of the final reaction mixture showed that almost all of the fluorescence intensity
and Zn2+ were found in the high molecular weight fractions. In addition, TPEN reversed the
integrated fluorescence intensity of the proteome fractions almost by 50%. These results imply
that ZP1 reacts with Zn2+ that adventitiously binds proteome, and forms Proteome•Zn-ZP1
ternary adduct.
The generation of ternary adduct, Proteome•Zn-ZP1, was further supported from the reaction
between isolated proteome and ZP1(Zn)2. The reaction caused a red-shift of the emission
maximum to 540 nm from ZP(Zn)2’s 525 nm peak. Furthermore, following gel filtration of the
final reaction mixture, most of the fluorescence and almost all of the zinc were located in the
high molecular weight fractions. TPEN reduced the integrated fluorescence intensity of the high
molecular weight fractions by almost 82%.
The titration of ZP1 with alcohol dehydrogenase (Zn-ADH), used as a model Zn-protein,
displayed a gradual enhancement of fluorescence at 536 nm, which was reversed almost
completely by TPEN. This suggested the generation of ternary adduct ZP1-Zn-ADH between ZP1
and alcohol dehydrogenase followed by the possible displacement of ZP1 by TPEN to form
TPEN-Zn-ADH. The TPEN reaction is consistent with the previous studies which demonstrated
that it binds Zn-ADH in the form of TPEN-Zn-ADH.67 However, the continuing increase of
fluorescence even at the concentration of alcohol dehydrogenase that contained Zn 2+ six times
higher than the concentration of ZP1 indicated that the interaction between ZP1 and Zn-ADH to
form ZP1-Zn-ADH is weak. The location of the majority of the fluorescence in the low molecular
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weight fractions – which resulted from ZP1’s intrinsic fluorescence - following the gel filtration
of the final reaction mixture of the reaction between ZP1 and alcohol dehydrogenase further
supported the weak interaction ZP1 and Zn-ADH that was disrupted during the gel filtration.
Taken together, the reactions of ZP1 with LLC-PK1 cells, isolated proteome and model proteins,
such as alcohol dehydrogenase in the absence or presence of externally added Zn 2+ suggested
that ZP1 reacts with Zn-Proteome and results in the formation of ternary adduct ZP1-ZnProteome with native Zn-Proteome or Proteome•Zn-ZP1 with externally added Zn2+ and
proteome. Therefore, the use of ZP1 to image cellular free or labile Zn 2+ is complicated as it also
images Zn-protein. Thus, careful investigations are required in the studies that employ ZP1 to
image free or labile Zn2+.
The titrations of isolated proteome with externally added Zn2+ in the presence of Newport
Green or Zinpyr-1 were carried out as model reactions to mimic the release of Zn2+ from various
intracellular Zn2+ stores such as endoplasmic reticulum, vesicles etc. which have been imaged
by different fluorescent sensors in various studies. However, we have seen that in those model
reactions, NPGA cannot compete with proteome for the added Zn2+ until very high
concentrations of Zn2+ were added. And ZP1 formed ternary adduct, Proteome•Zn-ZP1, with
Zn2+ that is adventitiously bound to proteome. In neither case did the sensor image free Zn 2+ as
various studies claimed. Therefore, the studies which used a fluorescent Zn 2+ sensor to sense
Zn2+ released from intracellular stores or liberated from Zn-proteome followed by the
introduction of a physiological or pathological agent that induced the liberation of Zn 2+ need
further study.
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To put the results of those model Zn2+ release experiments into cellular context, we studied the
reaction of nitric oxide (NO) with cellular or isolated Zn-proteome. A number of studies
reported the imaging of free Zn2+ liberated following the incubation of cells with NO by
fluorescent sensors.54, 56, 109, 110 In one early study, sheep pulmonary alveolar endothelial cells
(SPAEC) exposed to the NO donor, S-NO-cysteine, and ZQ displayed a 25% increase in
fluorescence compared with controls, which led to the conclusion that Zn2+ mobilized by NO
plays a key role in NO-dependent vessel constriction.56

The present work examines the

reaction of LLC-PK1 cells or isolated proteome with another NO donor, diethylamine NONOate
(DEA-NO), with fluorescent sensors having varied binding affinities for Zn 2+.
The reaction of LLC-PK1 cells with Zinquin (ZQ) reacted with 15-20% of Zn-proteome as
expected and generated the ternary adduct species ZQ-Zn-Proteome – evident from the
appearance of 470 nm emission maximum. Upon the subsequent introduction of DEA-NO,
fluorescence further increased at 470 nm, indicating the formation of additional ternary adduct
species. In addition, along with 470 nm, 490 nm emission, characteristic of Zn(ZQ) 2 complex
formation, appeared. The gel filtration of the cell lysate once again supported the generation of
both ternary adduct species and the Zn(ZQ)2 complex. Together, these results suggested that
Zn2+ mobilized from Zn-proteome upon NO exposure binds adventitiously to various proteomic
sites possessing zinc binding affinity. The excess ZQ then makes additional ternary adduct
species Proteome•Zn-ZQ, which accounts for the fluorescence increase at 470 nm. Due to its
high stability constant of Zn2+ binding, ZQ can also generate some Zn(ZQ)2 complex through
ligand substitution. These results can be described by the following equations:
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Zn-S-Proteome + NO ⇌ NO-S-Proteome + Zn2+
Proteome + Zn2+ ⇌Proteome•Zn
Proteome•Zn + ZQ ⇌ Proteome•Zn-ZQ (470 nm)
Proteome•Zn + 2ZQ ⇌ Proteome + Zn(ZQ)2 (490 nm)
The results were verified with the reaction of isolated proteome with ZQ followed by DEA-NO.
When the reaction was repeated with another zinc sensor TSQ, closely related to ZQ structure,
along with TSQ-Zn-Proteome ternary adduct generated from the reaction of TSQ and 15-20% of
the native Zn-proteome, additional ternary adduct species Proteome•Zn-TSQ formed through
similar mechanism as of ZQ. However, because it is a weaker sensor than ZQ, TSQ could not
form any Zn(TSQ)2 complex by chelating Zn2+ from Proteome•Zn. This explanation is consistent
with our previous result of the reaction of proteome with DEA-NO in the presence of Newport
Green. Since Newport Green is a weak zinc sensor, it could not compete with proteome for the
liberated Zn2+, and thus was unable to form any measurable Zn-NPG. However, in both cases,
proteomic sulfhydryl concentration were significantly reduced, confirming the reaction of NO
and proteomic sulfhydryl groups, which resulted the liberation of proteomic Zn 2+.
To further validate the results of ZQ and TSQ experiments, isolated proteome pre-treated with
ZQ or TSQ was titrated with Zn2+, a model used to mimic liberation of Zn2+ following NO
exposure. As anticipated in both cases, additional ternary adduct Proteome•Zn-ZQ/TSQ was
generated from the reaction of ZQ/TSQ and Zn2+ adventitiously bound to proteome,
Proteome•Zn. However, unlike NO experiment with ZQ, no Zn(ZQ)2 complex was produced. This
implied that proteome’s adventitious zinc binding sites perhaps involve sulfhydryl groups. Since
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a significant number of these sulfhydryl groups are modified by NO in the DEA-NO experiment,
some of the mobilized Zn2+ may be unable to bind these sites and become accessible to ZQ to
produce the Zn(ZQ)2 complex. By contrast, in this titration experiment, due to the absence of
added sulfhydryl binding agent, most of the proteomic sulfhydryl groups are unmodified and
thus prevent ZQ from binding any added Zn2+ to form Zn(ZQ)2 complex.
Having found that ZQ and TSQ, due to their difference in zinc binding affinity, reacted
differently with proteome exposed to DEA-NO, we turned to a third sensor FluoZin-3, another
zinc sensor with intermediate binding affinity (15 nM) between TSQ and ZQ. 1 Unlike ZQ and
TSQ, FluoZin-3 does not react with native Zn-proteome. Following exposure of proteome
incubated with FluoZin-3 to DEA-NO, a gradual increase of fluorescence insensitive to TPEN was
observed, suggesting that the fluorescence increase due to the modification of the fluorophore,
not because of the binding of Zn2+. Evidently, FluoZin-3, like Newport Green, reacts
independently with nitric oxide (NO) accompanied by fluorescence enhancement. In this case,
neither Proteome•Zn-FluoZin3 ternary adduct nor Zn-FluoZin3 could be detected. This
suggested that FluoZin-3 cannot effectively competed for Zn2+ with modified or adventitious
proteomic binding sites.
Thus, three different results were obtained from the reaction of proteome with the nitric oxide
donor, DEA-NO, depending on the zinc binding affinity of the fluorescent sensor used. This
clearly demonstrates that the Zn2+ binding properties of proteome under different cellular
conditions, e.g. proteomic sulfhydryl groups modified by NO in this case play an important role
to determine how the zinc sensor will function. For example, among the three sensors used in
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this study, ZQ could effectively compete with proteome for the mobilized Zn 2+, only when the
proteomic zinc binding sites were modified by NO. Therefore, the imaging of Zn 2+ labilized by
the exposure of NO depends on the zinc binding characteristics of the proteome and the
relative zinc binding affinity of the sensor compared with that of proteome’s adventitious sites.
That proteome has numerous high affinity Zn2+ binding sites as revealed in the above titration
experiment suggests that Zn2+ may be transported to native Zn-proteins via ligand substitution
involving these non-specific high affinity sites.
Apart from doubting the effectiveness of a large number of zinc sensors to image labile Zn 2+
within the proteomic environment, the apparent strong affinity of mobilizable Zn2+ for the
above mentioned non-specific proteomic binding sites raises other important questions. For
example, if the proteome provides a strong buffer for Zn 2+, how does intracellular Zn2+ signaling
take place?
From a number of experiments, including the titration of proteome with Zn 2+ in the presence of
Newport Green, ZP1, TSQ, Zinquin and FluoZin-3, it is convincingly evident that beside the
strong Zn2+ binding sites in native Zn-proteins, proteome has a large number of high affinity
adventitious zinc binding sites. However, as was seen in the reaction of proteome incubated
with ZQ and DEA-NO, nitric oxide (NO) significantly modified the proteomic sulfhydryl groups,
which coincided with the proteome’s reduction of zinc buffering capacity and as such ZQ could
effectively compete with proteome to generate Zn(ZQ)2 complex. This observation led us to the
hypothesis that proteomic sulfhydryl groups are primarily involved in these adventitious high
affinity Zn2+ binding sites. To examine this idea further, proteomic sulfhydryl groups were
modified by thiol binding reagents, such as N-ethylmaleimide (NEM) and 5,5-dithio-bis-(2171

nitrobenzoic acid) (DTNB), before treatment with Zn 2+. Interestingly, when the proteome was
incubated with NEM or DTNB, its high affinity Zn2+ binding sites were significantly reduced, as
monitored by both FluoZin-3 and Newport Green. This finding clearly implicated proteomic
sulfhydryl (-SH) groups as the high affinity zinc binding sites that outcompeted FluoZin-3 for the
added Zn2+. This discovery takes us one step further into understanding the mechanism of
cellular zinc trafficking. Moreover, this finding once again draws attention to the fact that the
ability of the sensor to image free or labile Zn2+ is contingent on the proteome’s Zn2+ binding
characteristics. For example, reaction of nitric oxide (NO) with the proteomic sulfhydryl (SH)
groups reduces their availability to bind Zn2+ in the presence of ZQ and other sensors, and this
proteomic condition allows the sensors to bind Zn 2+ accompanied by a fluorescence
enhancement. Various studies reported that the release of Zn 2+, induced by the exposure of
nitric oxide donors, precedes a Zn-dependent regulatory/signaling process, often inferred from
the fluorescence increase of the zinc sensor used. However, the sensor’s ability to bind Zn 2+
might be dependent on the diminished zinc buffering capacity of proteome resulting from the
modification of the sulfhydryl groups by NO. We know this because in unperturbed condition
of the proteome, most of the fluorescent zinc sensors, including high affinity sensors Zinquin
and FluoZin-3, are unable to bind mobile Zn2+. The pioneering discovery by Meeusen et al. that
inspired this investigation of the chemical biology of fluorescent zinc sensors, such as Newport
Green and Zinpyr-1, was that TSQ images Zn-proteins, not free Zn2+, through the formation of
ternary adduct TSQ-Zn-Protein – evident from its signature emission maximum of 470 nm,
unlike the Zn(TSQ)2 complex that displays 490 nm emission maximum. The incubation of LLCPK1 cells with TSQ followed by Zn(Pyrithione)2 resulted in bright fluorescence, as observed
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under fluorescence microscope, due to the formation of TSQ-Zn-Proteome ternary adduct and
TPEN, a strong Zn2+ chelator, reversed the fluorescence to a significant measure. However, the
bright fluorescence following the introduction of TSQ and Zn(Pyrithione) 2 was not
symmetrically distributed among the cells – some showed much more intense fluorescence
than others. Seeking the reason for this asymmetric fluorescence among the cells led us to the
hypothesis that cells at different stages of the cell cycle make unequal concentrations of
particular Zn-proteins. In turn, this may account for the unequal brightness of fluorescence in
different cells within a normal population of dividing cells.
CCRF cells were synchronized at G1 phase by the treatment with thymidine and subsequently
reacted with TSQ/Zinquin. Cells showed twice as much fluorescence and zinc content per cell
as the untreated population. The proteome isolated from thymidine treated CCRF cells
displayed similar results. By contrast, proteome isolated from cells synchronized at G2/M phase
by the incubation with nocodazole and its subsequent reaction with TSQ/ZQ resulted in about
half of the fluorescence intensity and two-third of the zinc content as the untreated cells.
Together, these findings supported the hypothesis that cells synthesize different amounts of
zinc proteins at different stages of its cell cycle. The results explain the non-uniform brightness
of fluorescence among the neighboring cells following the treatment with TSQ and
Zn(Pyrithione)2 observed by Meeusen et al.65
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5. SUMMARY
Taken altogether, this study has yielded some important discoveries, which are significant to
the understanding of the biological chemistry of the fluorescent zinc sensors, particularly
Newport Green and Zinpyr-1, and also, of cellular zinc trafficking. We have shown that due to
its modest Zn2+ binding affinity and as such its inability to outcompete proteome for Zn 2+,
Newport Green, by itself, cannot act as an effective sensor to image labile Zn 2+ within the
proteomic environment. Moreover, some of its unwanted properties, such as the slow
hydrolysis of its weakly fluorescent ester form into the strongly fluorescent acid form, and its
efflux into the extracellular medium, further complicate its use as a cellular Zn 2+ sensor. The
study of Zinpyr-1 has exposed its ability to generate ZP1-Zn-Proteome ternary adduct – both
with native Zn-Proteome and with proteome and the added Zn 2+. In addition, the weaker
fluorescence signal resulting from the first Zn2+ binding with higher affinity makes its use as a
cellular sensor even more convoluted.
The reaction of the proteome with diethylamine NONOate (DEA-NO) monitored by three
different sensors – Zinquin, TSQ and FluoZin-3 – revealed that the formation of Zn-Sensor
complex following the liberation of Zn2+ from Zn-proteome is dependent on the relative binding
affinity of the sensor used. The reaction with Zinquin (ZQ), a high affinity sensor, yielded a
significant quantity of Zn(ZQ)2, whereas no measurable Zn(TSQ)2 or Zn-FluoZin3 was formed
from the reactions of DEA-NO modified Zn-proteome with TSQ or FluoZin-3, relatively lower
affinity sensors than Zinquin.

174

The titration experiment of proteome incubated with FluoZin-3 with Zn2+ resulted in the
important finding that proteome possesses a large concentration of high affinity Zn 2+ binding
sites having Kd for Zn2+ on the order of 10-10 M. These high affinity Zn2+ binding sites may serve
as intermediate carriers of Zn2+, following entry into the cell, to convey Zn2+ to apo-proteins to
form native Zn-proteins - a pathway still not well understood. Following on, we have discovered
that these high affinity Zn2+ binding sites of proteome use sulfhydryl groups to bind Zn2+,
evident from the abolition of these sites when proteome was reacted with sulfhydryl binding
reagents, such as N-ethylmaleimide (NEM) and 5,5-dithio-bis-(2-nitrobenzoic acid) (DTNB). This
finding will drive us further into the understanding of the intermediate pathway of Zn-protein
formation. Last but not least, the cell cycle study has resulted in another important revelation
that cells synthesize varied amount of zinc proteins at different stages of the cell cycle. All these
findings will, surely, enhance the overall understanding of the cellular zinc trafficking between
and within the cellular compartments.
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